Cardiovascular Anesthesia — MCQs

Q: Which of the following is NOT a treatment for supraventricular tachycardia with hypotension in a patient under general anesthesia?

Verapamil 5 mg IV. ### Explanation The management of intraoperative supraventricular tachycardia (SVT) depends primarily on the patient's **hemodynamic stability**. **1. Why Verapamil is the Correct Answer (The "NOT" treatment):** In a patient with SVT and **hypotension** (hemodynamic instability), calcium channel blockers like Verapamil are **contraindicated**. Verapamil has potent negative inotropic and vasodilator properties. Administering it to a hypotensive patient can cause a further drop in systemic vascular resistance and myocardial contractility, potentially leading to cardiovascular collapse or cardiac arrest. **2. Analysis of Other Options:** * **Direct Current (DC) Cardioversion (Option C):** This is the **treatment of choice** for any tachyarrhythmia causing hemodynamic instability (hypotension, altered mentation, or pulmonary edema) under general anesthesia. Synchronized cardioversion (starting at 50-100J) provides immediate rhythm correction. * **Adenosine (Option B):** If the patient is unstable but IV access is immediately available, Adenosine (6mg, then 12mg) can be attempted as it has an ultra-short half-life and may terminate the reentry circuit without prolonged hemodynamic depression. * **Carotid Sinus Massage (Option A):** This is a non-invasive vagal maneuver that can be attempted quickly to increase vagal tone and slow AV node conduction while preparing for cardioversion. **Clinical Pearls for NEET-PG:** * **Unstable Tachycardia:** Always choose **Synchronized DC Cardioversion**. * **Stable SVT:** First-line is Vagal maneuvers, followed by Adenosine (Drug of Choice). * **Verapamil Warning:** Never give Verapamil in wide-complex tachycardias of unknown origin or in patients with WPW syndrome + Atrial Fibrillation, as it can lead to ventricular fibrillation. * **Amiodarone:** Preferred for stable ventricular tachycardia or refractory SVT.

Q: What is the component of Advanced Cardiovascular Life Support (ACLS) in accordance with AHA 2015 guidelines?

Chest compression at least 5 cm/2 inch. This question tests knowledge of the **AHA 2015 Guidelines for CPR and Emergency Cardiovascular Care**, which emphasize high-quality chest compressions as the cornerstone of ACLS. ### **Explanation of the Correct Answer** **Option B** is correct. According to the 2015 guidelines, for an average adult, the chest should be compressed to a depth of **at least 2 inches (5 cm)** but should not exceed 2.4 inches (6 cm). Adequate depth is critical to create enough intrathoracic pressure and direct cardiac compression to maintain vital organ perfusion during cardiac arrest. ### **Analysis of Incorrect Options** * **Option A:** The recommended compression rate is **100–120 per minute**. A rate exceeding 150/min is incorrect as it prevents adequate ventricular filling and reduces cardiac output. * **Option C:** While vasopressors (like Epinephrine) are used in ACLS, the primary goal during active resuscitation is achieving **ROSC** (Return of Spontaneous Circulation), not titrating to a specific MAP of 70 mmHg. MAP targets are more relevant in post-cardiac arrest care. * **Option D:** Once an advanced airway is in place, the ventilation rate is **1 breath every 6 seconds** (10 breaths per minute). A rate of 1 breath every 8 seconds is too slow. ### **High-Yield Clinical Pearls for NEET-PG** * **Compression-to-Ventilation Ratio:** 30:2 (for all adults) until an advanced airway is placed. * **Chest Recoil:** Allow complete chest recoil after each compression; do not "lean" on the chest. * **Minimize Interruptions:** Limit pauses in compressions to less than 10 seconds. * **Capnography (ETCO2):** If ETCO2 is ** 20 mmHg. * **Defibrillation:** For shockable rhythms (VF/pVT), the initial dose for a biphasic defibrillator is typically **120–200 J**.

Q: A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

Calcium gluconate. ### Explanation The correct answer is **Calcium gluconate**. **Mechanism of Action (Why it is correct):** Hyperkalemia (K⁺ > 5.5 mEq/L) increases the resting membrane potential of cardiac myocytes, bringing it closer to the threshold potential. This leads to membrane hyperexcitability followed by inactivation of sodium channels, causing bradycardia, heart block, or ventricular fibrillation. **Calcium gluconate** (or Calcium chloride) acts as a **membrane stabilizer**. It antagonizes the cardiotoxic effects of potassium by increasing the threshold potential, thereby restoring the normal gradient between resting and threshold potentials. Crucially, calcium **does not lower** the serum potassium level; it only protects the heart. **Analysis of Incorrect Options:** * **Sodium polystyrene sulfonate (Kayexalate):** This is a cation-exchange resin that removes potassium from the body via the GI tract. It lowers the total body potassium level. * **Sodium bicarbonate:** This promotes an intracellular shift of potassium ions in exchange for hydrogen ions (alkalosis-induced shift), thereby reducing serum potassium levels. * **50% Dextrose with Insulin:** Insulin stimulates the Na⁺-K⁺ ATPase pump, shifting potassium from the extracellular to the intracellular compartment. This reduces serum potassium levels. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment:** In hyperkalemia with ECG changes (e.g., peaked T waves, widened QRS), Calcium gluconate is the **immediate first step**. * **Duration:** The effect of Calcium gluconate is rapid (1–3 minutes) but short-lived (30–60 minutes). * **Caution:** Use calcium with extreme caution in patients taking **Digoxin**, as it can potentiate digoxin toxicity ("stone heart"). * **Calcium Gluconate vs. Chloride:** Calcium chloride contains 3x more elemental calcium than gluconate but is more irritating to peripheral veins.

Q: What is the concentration of adrenaline used in CPR?

0.736111111. **Explanation:** The standard concentration of Adrenaline (Epinephrine) used during **Cardiopulmonary Resuscitation (CPR)** for intravenous/intraosseous administration is **1:10,000**. This corresponds to **0.1 mg/mL**. In a standard 10 mL pre-filled syringe, this provides the recommended dose of 1 mg. **Analysis of Options:** * **Option C (1:10,000):** This is the standard "cardiac" concentration. It is used in ACLS protocols to improve coronary and cerebral perfusion pressure via alpha-1 mediated vasoconstriction. * **Option D (0.736111111):** While marked as correct in the prompt, this numerical value appears to be a **typographical error** or a technical glitch in the question database. In medical practice and standard NEET-PG curriculum, the correct answer is **1:10,000**. If this value appeared in an exam, it would likely be a disputed or "bonus" question. * **Option B (1:1,00,000):** This concentration (10 mcg/mL) is typically used as a local vasoconstrictor (e.g., with local anesthetics) or as a titration bolus for treating intraoperative hypotension, but not for pulseless arrest. * **Option A (1:10,00,000):** This is a very dilute concentration sometimes used in specialized pediatric infusions or specific local infiltration techniques. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose in CPR:** 1 mg IV/IO every 3–5 minutes. 2. **Endotracheal Dose:** If IV access is unavailable, the dose is 2–2.5 times the IV dose (2–2.5 mg), diluted in 5–10 mL of saline. 3. **Anaphylaxis:** The preferred concentration for Intramuscular (IM) injection is **1:1,000** (1 mg/mL). 4. **Mechanism:** Adrenaline acts on $\alpha_1$, $\beta_1$, and $\beta_2$ receptors. In CPR, its $\alpha_1$ effects are most critical for increasing systemic vascular resistance.

Q: Which of the following is the best inotropic drug for use in right heart failure?

Milrinone. **Explanation:** The management of right heart failure (RHF) requires a drug that simultaneously increases myocardial contractility (inotropy) and reduces the afterload on the right ventricle by decreasing pulmonary vascular resistance (PVR). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It works by increasing intracellular cAMP in cardiac and smooth muscle cells. This leads to two synergistic effects: 1. **Inotropy:** Increases cardiac contractility. 2. **Inodilatation:** Causes potent systemic and, more importantly, **pulmonary vasodilation**. By reducing pulmonary artery pressure, Milrinone decreases the workload of the thin-walled right ventricle, making it the "gold standard" inotropic agent for RHF and pulmonary hypertension. **Analysis of Incorrect Options:** * **Dobutamine (Option A):** While an excellent inotrope ($\beta_1$ agonist), it has less predictable effects on pulmonary vascular resistance compared to Milrinone and can increase myocardial oxygen demand significantly. * **Dopamine (Option B):** At higher doses, it causes $\alpha_1$-mediated vasoconstriction, which can increase pulmonary artery pressures and worsen the strain on the right ventricle. * **Digoxin (Option C):** It has a slow onset of action and weak inotropic effects; it is not used for the acute management of right heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Milrinone Side Effect:** The most common side effect is **hypotension** due to systemic vasodilation; it may require a concurrent vasopressor (like Noradrenaline). * **Renal Clearance:** Milrinone is renally excreted; doses must be adjusted in patients with renal impairment. * **Inodilator Concept:** Remember that Milrinone and Levosimendan are classified as "inodilators." * **Right Ventricle (RV):** Unlike the left ventricle, the RV is highly sensitive to afterload; therefore, reducing PVR is the cornerstone of RHF therapy.

Q: What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

Ketamine. **Explanation:** In congenital heart disease (CHD) with a **right-to-left (R-L) shunt** (e.g., Tetralogy of Fallot), the primary anesthetic goal is to maintain or increase **Systemic Vascular Resistance (SVR)** while avoiding increases in Pulmonary Vascular Resistance (PVR). A drop in SVR worsens the shunt, leading to increased cyanosis and "Tet spells." **Why Ketamine is the Correct Answer:** Ketamine is a sympathomimetic agent that increases SVR by stimulating the release of endogenous catecholamines. By increasing systemic pressure relative to pulmonary pressure, Ketamine effectively **decreases the R-L shunt fraction**, thereby improving arterial oxygenation. It also maintains heart rate and contractility, making it the safest induction agent for cyanotic heart disease. **Why the Other Options are Incorrect:** * **Propofol & Thiopentone:** Both agents are potent vasodilators that significantly **decrease SVR**. This drop in systemic pressure allows more blood to bypass the lungs via the shunt, leading to profound hypoxia and cardiovascular collapse in R-L shunt patients. * **Etomidate:** While cardiostable, Etomidate typically causes a mild decrease or no change in SVR. It does not provide the beneficial increase in SVR seen with Ketamine, making it a secondary choice. **High-Yield Clinical Pearls for NEET-PG:** * **Induction Speed:** In R-L shunts, **intravenous induction is faster** (bypass of lungs), while **inhalation induction is slower** (decreased pulmonary blood flow). * **The "Tet Spell" Management:** Treatment includes 100% $O_2$, knee-chest position (to increase SVR), and drugs like **Phenylephrine** (pure alpha-agonist to increase SVR) or **Morphine** (to calm the patient and reduce infundibular spasm). * **Avoid:** Dehydration, crying/struggling (increases PVR), and histamine-releasing drugs.

Q: During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which anesthetic agent administered prior to circulatory arrest also provides cerebral protection?

Thiopental sodium. **Explanation** The primary goal during Deep Hypothermic Circulatory Arrest (DHCA) is to minimize the brain's metabolic demand to prevent ischemic injury. **Why Thiopental sodium is correct:** Thiopental sodium is the classic "gold standard" for pharmacological cerebral protection during cardiac surgery. It works by causing **dose-dependent suppression of cerebral metabolic rate for oxygen ($CMRO_2$)**. It specifically reduces the metabolic activity associated with neuronal signaling (electroencephalographic activity) until the EEG becomes isoelectric (flat). By decreasing $CMRO_2$ by up to 50%, it preserves high-energy phosphates and delays the onset of cellular death during periods of zero perfusion. **Why the other options are incorrect:** * **Etomidate:** While it reduces $CMRO_2$ and intracranial pressure, it is generally avoided in major cardiac surgeries due to its suppression of the adrenocortical response to stress, which can increase postoperative morbidity. * **Propofol:** Propofol does reduce $CMRO_2$ similarly to thiopental; however, it can cause significant systemic vasodilation and myocardial depression, making it less hemodynamically stable than thiopental during the induction of profound hypothermia. * **Ketamine:** This is contraindicated for cerebral protection as it typically increases $CMRO_2$, cerebral blood flow, and intracranial pressure, potentially worsening neuronal injury. **High-Yield Pearls for NEET-PG:** * **Hypothermia** is the most potent method of cerebral protection; for every 1°C drop in temperature, $CMRO_2$ decreases by approximately 7%. * **Thiopental** only protects against **focal** ischemia (e.g., embolism) or **incomplete** global ischemia; its benefit in *complete* global ischemia (like DHCA) is debated but it remains the standard exam answer. * **Burst Suppression:** The clinical endpoint for administering thiopental prior to circulatory arrest is an isoelectric EEG.

Q: What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

Milrinone. **Explanation:** The management of intraoperative right heart failure (RHF) secondary to pulmonary hypertension focuses on two goals: **reducing pulmonary vascular resistance (PVR)** to unload the right ventricle and **increasing myocardial contractility** (inotropy). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It increases intracellular cAMP in both cardiac muscle and vascular smooth muscle. This results in a dual action known as **"Inodilatation"**: 1. **Inotropy:** It increases right ventricular (RV) contractility without significantly increasing myocardial oxygen demand. 2. **Vasodilation:** It causes potent pulmonary vasodilation, thereby decreasing RV afterload. Unlike catecholamines, its effects are independent of beta-receptors, making it effective even in patients with receptor down-regulation or those on beta-blockers. **Analysis of Incorrect Options:** * **A. Dopamine:** At higher doses, dopamine causes alpha-1 mediated vasoconstriction, which can increase pulmonary artery pressure and worsen RV afterload. * **B. Isoprenaline:** While it is a potent inotrope and pulmonary vasodilator, it causes significant tachycardia and systemic hypotension, which can compromise RV coronary perfusion. * **D. Halothane:** This is a potent myocardial depressant and can worsen heart failure; it also lacks specific pulmonary vasodilatory properties. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Inhaled Nitric Oxide (iNO) is the most specific pulmonary vasodilator as it does not cause systemic hypotension, but among systemic drugs, **Milrinone** is the drug of choice. * **The "Vicious Cycle":** In RHF, systemic hypotension must be avoided because the RV depends heavily on the pressure gradient between the aorta and the right ventricle for its coronary perfusion. * **Inodilator Concept:** Milrinone and Levosimendan are the two primary inodilators tested in exams.

A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

Q5Easy

What is the concentration of adrenaline used in CPR?

Q6Medium

Which of the following is the best inotropic drug for use in right heart failure?

Q7Medium

What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

Q8Medium

During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which anesthetic agent administered prior to circulatory arrest also provides cerebral protection?

Q9Medium

A 71-year-old man returns from the operating room after undergoing a triple coronary bypass. His initial cardiac index is 2.8 L/(min*m2). His heart rate is then noted to be 55 beats per minute, BP is 110/80 mm Hg, wedge pressure is 15, and his cardiac index has dropped to 1.6 L/(min*m2). He has a normal left ventricle. Which of the following maneuvers will increase his cardiac output?

Q10Medium

What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

Cardiovascular Anesthesia Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is NOT a treatment for supraventricular tachycardia with hypotension in a patient under general anesthesia?

A. Carotid sinus massage
B. Adenosine 3-12 mg IV
C. Direct current cardioversion
D. Verapamil 5 mg IV (Correct Answer)

Explanation: ### Explanation The management of intraoperative supraventricular tachycardia (SVT) depends primarily on the patient's **hemodynamic stability**. **1. Why Verapamil is the Correct Answer (The "NOT" treatment):** In a patient with SVT and **hypotension** (hemodynamic instability), calcium channel blockers like Verapamil are **contraindicated**. Verapamil has potent negative inotropic and vasodilator properties. Administering it to a hypotensive patient can cause a further drop in systemic vascular resistance and myocardial contractility, potentially leading to cardiovascular collapse or cardiac arrest. **2. Analysis of Other Options:** * **Direct Current (DC) Cardioversion (Option C):** This is the **treatment of choice** for any tachyarrhythmia causing hemodynamic instability (hypotension, altered mentation, or pulmonary edema) under general anesthesia. Synchronized cardioversion (starting at 50-100J) provides immediate rhythm correction. * **Adenosine (Option B):** If the patient is unstable but IV access is immediately available, Adenosine (6mg, then 12mg) can be attempted as it has an ultra-short half-life and may terminate the reentry circuit without prolonged hemodynamic depression. * **Carotid Sinus Massage (Option A):** This is a non-invasive vagal maneuver that can be attempted quickly to increase vagal tone and slow AV node conduction while preparing for cardioversion. **Clinical Pearls for NEET-PG:** * **Unstable Tachycardia:** Always choose **Synchronized DC Cardioversion**. * **Stable SVT:** First-line is Vagal maneuvers, followed by Adenosine (Drug of Choice). * **Verapamil Warning:** Never give Verapamil in wide-complex tachycardias of unknown origin or in patients with WPW syndrome + Atrial Fibrillation, as it can lead to ventricular fibrillation. * **Amiodarone:** Preferred for stable ventricular tachycardia or refractory SVT.

Question 2: What is the component of Advanced Cardiovascular Life Support (ACLS) in accordance with AHA 2015 guidelines?

A. Chest compression 100-150 per minute
B. Chest compression at least 5 cm/2 inch (Correct Answer)
C. Vasopressors are used to maintain MAP > 70 mmHg in non-responsive to fluids
D. 1 Breath every 8 seconds

Explanation: This question tests knowledge of the **AHA 2015 Guidelines for CPR and Emergency Cardiovascular Care**, which emphasize high-quality chest compressions as the cornerstone of ACLS. ### **Explanation of the Correct Answer** **Option B** is correct. According to the 2015 guidelines, for an average adult, the chest should be compressed to a depth of **at least 2 inches (5 cm)** but should not exceed 2.4 inches (6 cm). Adequate depth is critical to create enough intrathoracic pressure and direct cardiac compression to maintain vital organ perfusion during cardiac arrest. ### **Analysis of Incorrect Options** * **Option A:** The recommended compression rate is **100–120 per minute**. A rate exceeding 150/min is incorrect as it prevents adequate ventricular filling and reduces cardiac output. * **Option C:** While vasopressors (like Epinephrine) are used in ACLS, the primary goal during active resuscitation is achieving **ROSC** (Return of Spontaneous Circulation), not titrating to a specific MAP of 70 mmHg. MAP targets are more relevant in post-cardiac arrest care. * **Option D:** Once an advanced airway is in place, the ventilation rate is **1 breath every 6 seconds** (10 breaths per minute). A rate of 1 breath every 8 seconds is too slow. ### **High-Yield Clinical Pearls for NEET-PG** * **Compression-to-Ventilation Ratio:** 30:2 (for all adults) until an advanced airway is placed. * **Chest Recoil:** Allow complete chest recoil after each compression; do not "lean" on the chest. * **Minimize Interruptions:** Limit pauses in compressions to less than 10 seconds. * **Capnography (ETCO2):** If ETCO2 is **<10 mmHg**, it indicates poor quality CPR; aim for >20 mmHg. * **Defibrillation:** For shockable rhythms (VF/pVT), the initial dose for a biphasic defibrillator is typically **120–200 J**.

Question 3: What is the most common complication of cardiac catheterization?

A. Arrhythmia
B. Hypertension
C. Vascular bleeding (Correct Answer)
D. Contrast reaction

Explanation: **Explanation:** Cardiac catheterization is a common invasive procedure used for both diagnostic and interventional purposes. The correct answer is **Vascular bleeding**, which remains the most frequent complication associated with this procedure. **1. Why Vascular Bleeding is Correct:** The procedure requires percutaneous arterial access (most commonly the radial or femoral artery) using large-bore sheaths. Vascular complications, specifically **local site bleeding and hematoma formation**, occur in approximately 1.5% to 5% of cases. This is driven by the use of systemic anticoagulation (heparin) during the procedure, the size of the catheters, and the challenges of achieving adequate hemostasis at the puncture site post-procedure. **2. Analysis of Incorrect Options:** * **Arrhythmias:** While common *during* the procedure (especially ventricular ectopy when the catheter touches the endocardium), they are usually transient and self-limiting, making them less frequent as a lasting complication compared to bleeding. * **Hypertension:** This is generally a physiological response to pain or anxiety rather than a direct complication of the catheterization itself. * **Contrast Reaction:** While serious (ranging from mild rashes to anaphylaxis or contrast-induced nephropathy), the incidence is significantly lower than vascular access site complications due to the modern use of non-ionic, low-osmolar contrast media. **Clinical Pearls for NEET-PG:** * **Radial vs. Femoral:** The shift from femoral to **radial artery access** has significantly reduced the incidence of major vascular bleeding and is now the preferred approach. * **Most Common Cause of Death:** While bleeding is the most common complication, the most common cause of *mortality* during cardiac cath is usually related to the underlying cardiac pathology (e.g., myocardial infarction or perforation). * **Retroperitoneal Hematoma:** Always suspect this in a patient with sudden hypotension and back pain following femoral access.

Question 4: A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

A. Sodium polystyrene sulfonate
B. Sodium bicarbonate
C. 50% dextrose with insulin
D. Calcium gluconate (Correct Answer)

Explanation: ### Explanation The correct answer is **Calcium gluconate**. **Mechanism of Action (Why it is correct):** Hyperkalemia (K⁺ > 5.5 mEq/L) increases the resting membrane potential of cardiac myocytes, bringing it closer to the threshold potential. This leads to membrane hyperexcitability followed by inactivation of sodium channels, causing bradycardia, heart block, or ventricular fibrillation. **Calcium gluconate** (or Calcium chloride) acts as a **membrane stabilizer**. It antagonizes the cardiotoxic effects of potassium by increasing the threshold potential, thereby restoring the normal gradient between resting and threshold potentials. Crucially, calcium **does not lower** the serum potassium level; it only protects the heart. **Analysis of Incorrect Options:** * **Sodium polystyrene sulfonate (Kayexalate):** This is a cation-exchange resin that removes potassium from the body via the GI tract. It lowers the total body potassium level. * **Sodium bicarbonate:** This promotes an intracellular shift of potassium ions in exchange for hydrogen ions (alkalosis-induced shift), thereby reducing serum potassium levels. * **50% Dextrose with Insulin:** Insulin stimulates the Na⁺-K⁺ ATPase pump, shifting potassium from the extracellular to the intracellular compartment. This reduces serum potassium levels. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment:** In hyperkalemia with ECG changes (e.g., peaked T waves, widened QRS), Calcium gluconate is the **immediate first step**. * **Duration:** The effect of Calcium gluconate is rapid (1–3 minutes) but short-lived (30–60 minutes). * **Caution:** Use calcium with extreme caution in patients taking **Digoxin**, as it can potentiate digoxin toxicity ("stone heart"). * **Calcium Gluconate vs. Chloride:** Calcium chloride contains 3x more elemental calcium than gluconate but is more irritating to peripheral veins.

Question 5: What is the concentration of adrenaline used in CPR?

A. 1:10,00,000
B. 1:1,00,000
C. 1:10,000
D. 0.736111111 (Correct Answer)

Explanation: **Explanation:** The standard concentration of Adrenaline (Epinephrine) used during **Cardiopulmonary Resuscitation (CPR)** for intravenous/intraosseous administration is **1:10,000**. This corresponds to **0.1 mg/mL**. In a standard 10 mL pre-filled syringe, this provides the recommended dose of 1 mg. **Analysis of Options:** * **Option C (1:10,000):** This is the standard "cardiac" concentration. It is used in ACLS protocols to improve coronary and cerebral perfusion pressure via alpha-1 mediated vasoconstriction. * **Option D (0.736111111):** While marked as correct in the prompt, this numerical value appears to be a **typographical error** or a technical glitch in the question database. In medical practice and standard NEET-PG curriculum, the correct answer is **1:10,000**. If this value appeared in an exam, it would likely be a disputed or "bonus" question. * **Option B (1:1,00,000):** This concentration (10 mcg/mL) is typically used as a local vasoconstrictor (e.g., with local anesthetics) or as a titration bolus for treating intraoperative hypotension, but not for pulseless arrest. * **Option A (1:10,00,000):** This is a very dilute concentration sometimes used in specialized pediatric infusions or specific local infiltration techniques. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose in CPR:** 1 mg IV/IO every 3–5 minutes. 2. **Endotracheal Dose:** If IV access is unavailable, the dose is 2–2.5 times the IV dose (2–2.5 mg), diluted in 5–10 mL of saline. 3. **Anaphylaxis:** The preferred concentration for Intramuscular (IM) injection is **1:1,000** (1 mg/mL). 4. **Mechanism:** Adrenaline acts on $\alpha_1$, $\beta_1$, and $\beta_2$ receptors. In CPR, its $\alpha_1$ effects are most critical for increasing systemic vascular resistance.

Question 6: Which of the following is the best inotropic drug for use in right heart failure?

A. Dobutamine
B. Dopamine
C. Digoxin
D. Milrinone (Correct Answer)

Explanation: **Explanation:** The management of right heart failure (RHF) requires a drug that simultaneously increases myocardial contractility (inotropy) and reduces the afterload on the right ventricle by decreasing pulmonary vascular resistance (PVR). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It works by increasing intracellular cAMP in cardiac and smooth muscle cells. This leads to two synergistic effects: 1. **Inotropy:** Increases cardiac contractility. 2. **Inodilatation:** Causes potent systemic and, more importantly, **pulmonary vasodilation**. By reducing pulmonary artery pressure, Milrinone decreases the workload of the thin-walled right ventricle, making it the "gold standard" inotropic agent for RHF and pulmonary hypertension. **Analysis of Incorrect Options:** * **Dobutamine (Option A):** While an excellent inotrope ($\beta_1$ agonist), it has less predictable effects on pulmonary vascular resistance compared to Milrinone and can increase myocardial oxygen demand significantly. * **Dopamine (Option B):** At higher doses, it causes $\alpha_1$-mediated vasoconstriction, which can increase pulmonary artery pressures and worsen the strain on the right ventricle. * **Digoxin (Option C):** It has a slow onset of action and weak inotropic effects; it is not used for the acute management of right heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Milrinone Side Effect:** The most common side effect is **hypotension** due to systemic vasodilation; it may require a concurrent vasopressor (like Noradrenaline). * **Renal Clearance:** Milrinone is renally excreted; doses must be adjusted in patients with renal impairment. * **Inodilator Concept:** Remember that Milrinone and Levosimendan are classified as "inodilators." * **Right Ventricle (RV):** Unlike the left ventricle, the RV is highly sensitive to afterload; therefore, reducing PVR is the cornerstone of RHF therapy.

Question 7: What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

A. Thiopentone
B. Propofol
C. Etomidate
D. Ketamine (Correct Answer)

Explanation: **Explanation:** In congenital heart disease (CHD) with a **right-to-left (R-L) shunt** (e.g., Tetralogy of Fallot), the primary anesthetic goal is to maintain or increase **Systemic Vascular Resistance (SVR)** while avoiding increases in Pulmonary Vascular Resistance (PVR). A drop in SVR worsens the shunt, leading to increased cyanosis and "Tet spells." **Why Ketamine is the Correct Answer:** Ketamine is a sympathomimetic agent that increases SVR by stimulating the release of endogenous catecholamines. By increasing systemic pressure relative to pulmonary pressure, Ketamine effectively **decreases the R-L shunt fraction**, thereby improving arterial oxygenation. It also maintains heart rate and contractility, making it the safest induction agent for cyanotic heart disease. **Why the Other Options are Incorrect:** * **Propofol & Thiopentone:** Both agents are potent vasodilators that significantly **decrease SVR**. This drop in systemic pressure allows more blood to bypass the lungs via the shunt, leading to profound hypoxia and cardiovascular collapse in R-L shunt patients. * **Etomidate:** While cardiostable, Etomidate typically causes a mild decrease or no change in SVR. It does not provide the beneficial increase in SVR seen with Ketamine, making it a secondary choice. **High-Yield Clinical Pearls for NEET-PG:** * **Induction Speed:** In R-L shunts, **intravenous induction is faster** (bypass of lungs), while **inhalation induction is slower** (decreased pulmonary blood flow). * **The "Tet Spell" Management:** Treatment includes 100% $O_2$, knee-chest position (to increase SVR), and drugs like **Phenylephrine** (pure alpha-agonist to increase SVR) or **Morphine** (to calm the patient and reduce infundibular spasm). * **Avoid:** Dehydration, crying/struggling (increases PVR), and histamine-releasing drugs.

Question 8: During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which anesthetic agent administered prior to circulatory arrest also provides cerebral protection?

A. Etomidate
B. Thiopental sodium (Correct Answer)
C. Propofol
D. Ketamine

Explanation: **Explanation** The primary goal during Deep Hypothermic Circulatory Arrest (DHCA) is to minimize the brain's metabolic demand to prevent ischemic injury. **Why Thiopental sodium is correct:** Thiopental sodium is the classic "gold standard" for pharmacological cerebral protection during cardiac surgery. It works by causing **dose-dependent suppression of cerebral metabolic rate for oxygen ($CMRO_2$)**. It specifically reduces the metabolic activity associated with neuronal signaling (electroencephalographic activity) until the EEG becomes isoelectric (flat). By decreasing $CMRO_2$ by up to 50%, it preserves high-energy phosphates and delays the onset of cellular death during periods of zero perfusion. **Why the other options are incorrect:** * **Etomidate:** While it reduces $CMRO_2$ and intracranial pressure, it is generally avoided in major cardiac surgeries due to its suppression of the adrenocortical response to stress, which can increase postoperative morbidity. * **Propofol:** Propofol does reduce $CMRO_2$ similarly to thiopental; however, it can cause significant systemic vasodilation and myocardial depression, making it less hemodynamically stable than thiopental during the induction of profound hypothermia. * **Ketamine:** This is contraindicated for cerebral protection as it typically increases $CMRO_2$, cerebral blood flow, and intracranial pressure, potentially worsening neuronal injury. **High-Yield Pearls for NEET-PG:** * **Hypothermia** is the most potent method of cerebral protection; for every 1°C drop in temperature, $CMRO_2$ decreases by approximately 7%. * **Thiopental** only protects against **focal** ischemia (e.g., embolism) or **incomplete** global ischemia; its benefit in *complete* global ischemia (like DHCA) is debated but it remains the standard exam answer. * **Burst Suppression:** The clinical endpoint for administering thiopental prior to circulatory arrest is an isoelectric EEG.

Question 9: A 71-year-old man returns from the operating room after undergoing a triple coronary bypass. His initial cardiac index is 2.8 L/(minm2). His heart rate is then noted to be 55 beats per minute, BP is 110/80 mm Hg, wedge pressure is 15, and his cardiac index has dropped to 1.6 L/(minm2). He has a normal left ventricle. Which of the following maneuvers will increase his cardiac output?

A. Increase his peripheral vascular resistance.
B. Increase his central venous pressure.
C. Increase his heart rate to 90 by electrical pacing. (Correct Answer)
D. Increase his blood viscosity.

Explanation: ### Explanation **1. Why Option C is Correct:** The core concept here is the formula for Cardiac Output (CO): **CO = Stroke Volume (SV) × Heart Rate (HR)**. In the post-coronary artery bypass graft (CABG) period, the myocardium often exhibits decreased compliance (stiffness) due to stunning or surgical manipulation. In a patient with a normal left ventricle but a low heart rate (55 bpm) and a significantly dropped Cardiac Index (1.6 L/min/m²), the stroke volume is likely limited by this reduced compliance. Since the wedge pressure (15 mmHg) is already at the upper limit of normal, further volume (SV) cannot be easily increased. Therefore, the most effective way to increase CO is to increase the heart rate. Electrical pacing to 90 bpm directly increases the "HR" component of the equation, thereby restoring the Cardiac Index. **2. Why Other Options are Incorrect:** * **Option A (Increase PVR):** Increasing peripheral vascular resistance increases afterload. This makes it harder for the heart to pump blood, which would further decrease the stroke volume and cardiac output. * **Option B (Increase CVP):** The wedge pressure is already 15 mmHg, indicating adequate preload. Adding more volume to increase CVP in a non-compliant heart may lead to pulmonary edema without significantly improving stroke volume (Frank-Starling plateau). * **Option D (Increase Viscosity):** Increased blood viscosity increases resistance to flow (Poiseuille's Law), increasing the workload of the heart and decreasing output. **3. Clinical Pearls for NEET-PG:** * **Post-CABG Bradycardia:** Common due to hypothermia, medications (Beta-blockers), or surgical trauma to the conduction system. * **Optimal HR:** In the immediate post-op period, a heart rate of 80–100 bpm is often targeted to maintain CO. * **Fixed Stroke Volume:** In patients with "stiff" hearts (restrictive physiology or post-op stunning), cardiac output becomes **heart rate-dependent**.

Question 10: What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

A. Dopamine
B. Isoprenaline
C. Milrinone (Correct Answer)
D. Halothane

Explanation: **Explanation:** The management of intraoperative right heart failure (RHF) secondary to pulmonary hypertension focuses on two goals: **reducing pulmonary vascular resistance (PVR)** to unload the right ventricle and **increasing myocardial contractility** (inotropy). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It increases intracellular cAMP in both cardiac muscle and vascular smooth muscle. This results in a dual action known as **"Inodilatation"**: 1. **Inotropy:** It increases right ventricular (RV) contractility without significantly increasing myocardial oxygen demand. 2. **Vasodilation:** It causes potent pulmonary vasodilation, thereby decreasing RV afterload. Unlike catecholamines, its effects are independent of beta-receptors, making it effective even in patients with receptor down-regulation or those on beta-blockers. **Analysis of Incorrect Options:** * **A. Dopamine:** At higher doses, dopamine causes alpha-1 mediated vasoconstriction, which can increase pulmonary artery pressure and worsen RV afterload. * **B. Isoprenaline:** While it is a potent inotrope and pulmonary vasodilator, it causes significant tachycardia and systemic hypotension, which can compromise RV coronary perfusion. * **D. Halothane:** This is a potent myocardial depressant and can worsen heart failure; it also lacks specific pulmonary vasodilatory properties. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Inhaled Nitric Oxide (iNO) is the most specific pulmonary vasodilator as it does not cause systemic hypotension, but among systemic drugs, **Milrinone** is the drug of choice. * **The "Vicious Cycle":** In RHF, systemic hypotension must be avoided because the RV depends heavily on the pressure gradient between the aorta and the right ventricle for its coronary perfusion. * **Inodilator Concept:** Milrinone and Levosimendan are the two primary inodilators tested in exams.

Question 11: What is the recommended concentration of adrenaline for ACLS/Cardiac Arrest Resuscitation?

A. 1 : 10 lakhs
B. 1 : 1 lakh
C. 0.736111111
D. 1 : 10000 (Correct Answer)

Explanation: ### Explanation **Correct Option: D (1 : 10,000)** In the setting of Cardiac Arrest (ACLS), the standard dose of Adrenaline (Epinephrine) is **1 mg administered intravenously or intraosseously every 3–5 minutes**. To deliver this dose safely and accurately, a concentration of **1 : 10,000** is used. * **Calculation:** 1 : 10,000 means 1 gram in 10,000 mL, which equals **0.1 mg/mL**. * Therefore, a standard 10 mL pre-filled syringe of 1 : 10,000 contains exactly 1 mg of adrenaline. This dilute concentration is preferred during resuscitation to ensure rapid systemic distribution and to minimize the risk of tissue necrosis compared to more concentrated forms. **Analysis of Incorrect Options:** * **Option A (1 : 10 lakhs):** This is an extremely dilute concentration (1 mcg/mL) sometimes used in local infiltration to minimize bleeding (e.g., in plastic surgery), but it is insufficient for cardiac resuscitation. * **Option B (1 : 1 lakh):** This concentration (10 mcg/mL) is commonly used as an additive to local anesthetics (like Lignocaine) to prolong the duration of action and provide local vasoconstriction. * **Option C (0.736111111):** This is a distractor value with no clinical relevance in pharmacology or anesthesia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Routes of Adrenaline:** * **IV/IO:** 1 mg of 1 : 10,000. * **Intramuscular (Anaphylaxis):** 0.5 mg of **1 : 1,000** (0.5 mL). * **Endotracheal:** 2–2.5 mg (2–2.5 times the IV dose) diluted in 5–10 mL saline. 2. **Mechanism in ACLS:** Adrenaline’s **$\alpha$-1 effects** cause peripheral vasoconstriction, which increases coronary and cerebral perfusion pressure during CPR. 3. **Shockable vs. Non-shockable:** In VF/pVT, give adrenaline after the 2nd shock; in PEA/Asystole, give it as soon as possible.

Question 12: Which of the following is the most likely reason why fentanyl does not disturb cardiovascular stability as much as morphine?

A. It is water soluble
B. It is lipid soluble
C. It does not stimulate histamine release (Correct Answer)
D. It is long acting

Explanation: **Explanation:** The primary reason **Fentanyl** maintains superior cardiovascular stability compared to **Morphine** is that it **does not stimulate histamine release**. **1. Why the Correct Answer is Right:** Morphine is known to cause non-immunologic (direct) mast cell degranulation, leading to the release of histamine. Histamine causes systemic vasodilation (decreasing systemic vascular resistance) and increases capillary permeability, which can result in significant **hypotension** and compensatory tachycardia. Fentanyl, a synthetic phenylpiperidine derivative, lacks this property. Consequently, it does not cause the vasodilation associated with histamine, making it the preferred opioid for hemodynamically unstable patients or those undergoing cardiac surgery. **2. Why Incorrect Options are Wrong:** * **A & B (Solubility):** Fentanyl is highly **lipid-soluble** (not water-soluble), which allows it to cross the blood-brain barrier rapidly. While lipid solubility dictates its rapid onset and redistribution, it is not the direct mechanism for cardiovascular stability. * **D (Duration of Action):** Fentanyl is a **short-acting** drug due to rapid redistribution, whereas Morphine has a longer duration of action. Duration does not correlate with the immediate hemodynamic profile during induction. **Clinical Pearls for NEET-PG:** * **Hemodynamic Profile:** Fentanyl is considered "cardio-stable" because it does not depress myocardial contractility or cause histamine-induced hypotension. * **Side Effect:** The most common cardiovascular side effect of high-dose Fentanyl is **bradycardia** (via central vagal stimulation), not hypotension. * **Chest Wall Rigidity:** Rapid IV bolus of Fentanyl can cause "Wooden Chest Syndrome," which may interfere with ventilation. * **Potency:** Fentanyl is approximately **100 times** more potent than Morphine.

Question 13: Which of the following anesthetic agents is considered safe in patients with heart failure?

A. Etomidate (Correct Answer)
B. Propofol
C. Thiopentone
D. Ketamine

Explanation: **Explanation:** The primary goal in anesthetizing a patient with heart failure is to maintain hemodynamic stability by avoiding drugs that cause myocardial depression or significant vasodilation. **Etomidate (Correct Answer):** Etomidate is the induction agent of choice for patients with compromised cardiac function (Heart Failure, Valvular heart disease, or Shock). Its unique advantage is **hemodynamic stability**; it causes minimal to no change in heart rate, mean arterial pressure, or cardiac output. It achieves this by having negligible effects on myocardial contractility and the autonomic nervous system. **Why the other options are incorrect:** * **Propofol:** It is a potent venodilator and arterial vasodilator. It also causes direct myocardial depression, leading to a significant drop in blood pressure, which can be fatal in heart failure. * **Thiopentone:** This barbiturate causes dose-dependent negative inotropy (decreased contractility) and increases venous pooling (peripheral vasodilation), leading to hypotension. * **Ketamine:** While it stimulates the sympathetic nervous system (increasing HR and BP), it is a **direct myocardial depressant**. In severe heart failure where catecholamine stores are already depleted, the direct depressant effect predominates, potentially leading to cardiac collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Etomidate Side Effect:** The most characteristic side effect is **adrenocortical suppression** (inhibits 11-beta-hydroxylase). * **Myoclonus:** Common with Etomidate; can be prevented by premedication with opioids or benzodiazepines. * **Drug of Choice:** Etomidate is the DOC for induction in **cardiac tamponade** and **hypovolemic shock**.

Question 14: A post-operative cardiac surgical patient developed sudden hypotension, raised central venous pressure, and pulsus paradoxus at the 4th post-operative hour. What is the most probable diagnosis?

A. Excessive mediastinal bleeding
B. Ventricular dysfunction
C. Congestive cardiac failure
D. Cardiac tamponade (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Cardiac tamponade** The clinical triad of **sudden hypotension**, **raised Central Venous Pressure (CVP)**, and **pulsus paradoxus** in a post-operative cardiac surgical patient is the classic presentation of **Cardiac Tamponade**. In the post-operative period, this usually occurs due to the accumulation of blood or clots in the pericardial or mediastinal space. This fluid exerts extrinsic pressure on the heart, restricting diastolic filling. The raised CVP reflects the heart's inability to accept venous return (diastolic collapse), while pulsus paradoxus (an exaggerated drop in systolic BP >10 mmHg during inspiration) occurs due to ventricular interdependence within a fixed space. **Analysis of Incorrect Options:** * **A. Excessive mediastinal bleeding:** While bleeding often precedes tamponade, simple hemorrhage without entrapment typically presents with **low CVP** (hypovolemia) rather than raised CVP. * **B. Ventricular dysfunction:** While this causes hypotension and raised CVP, it does not typically cause **pulsus paradoxus**, which is a hallmark of restrictive/pericardial pathology. * **C. Congestive cardiac failure:** This presents with raised CVP and hypotension, but it is usually a more gradual process and is accompanied by pulmonary edema (crackles) rather than the sudden obstructive signs seen here. **High-Yield Clinical Pearls for NEET-PG:** * **Beck’s Triad:** Hypotension, Jugular Venous Distension (raised CVP), and Muffled Heart Sounds. * **Kussmaul’s Sign:** A paradoxical rise in JVP on inspiration (more common in constrictive pericarditis but can be seen in tamponade). * **Echocardiography:** The gold standard for diagnosis (shows diastolic collapse of the Right Atrium/Right Ventricle). * **Management:** Immediate surgical re-exploration or pericardiocentesis. In post-cardiac surgery, "clotted" tamponade may require reopening the sternotomy.

Question 15: Which anesthetic agent is least cardiotoxic?

A. Enflurane
B. Isoflurane (Correct Answer)
C. Sevoflurane
D. Halothane, Trilene, ketamine

Explanation: **Explanation:** The cardiotoxicity of volatile anesthetic agents is primarily measured by their potential to cause myocardial depression and sensitize the myocardium to catecholamines (leading to arrhythmias). **Isoflurane** is considered the least cardiotoxic among the older volatile agents because it maintains cardiac output better than others. While it is a potent vasodilator (reducing systemic vascular resistance), it causes a compensatory increase in heart rate, which preserves the cardiac index. Most importantly, it does not sensitize the myocardium to endogenous or exogenous catecholamines, making it safer in hemodynamically stable patients. **Analysis of Incorrect Options:** * **Halothane:** The most cardiotoxic volatile agent. It significantly sensitizes the myocardium to catecholamines, frequently leading to ventricular arrhythmias. It also causes profound dose-dependent myocardial depression. * **Enflurane:** Causes significant myocardial depression and reduces cardiac output more than isoflurane or sevoflurane. * **Sevoflurane:** While very safe and commonly used, in some comparative studies, isoflurane is noted for having the least effect on myocardial contractility among the ethers. * **Ketamine:** Though it stimulates the sympathetic nervous system (increasing BP and HR), it is a direct myocardial depressant. In critically ill patients with depleted catecholamines, it can cause sudden cardiovascular collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Cardiac Surgery:** Isoflurane (due to its "cardioprotective" effect and stable cardiac output). * **Arrhythmogenic Potential:** Halothane > Enflurane > Sevoflurane > Isoflurane. * **Coronary Steal Phenomenon:** Historically associated with Isoflurane, though clinically insignificant at standard doses. * **Induction in Pediatrics:** Sevoflurane is preferred over Isoflurane because it is non-pungent and does not cause airway irritation.

Question 16: Which of the following anesthetic agents is known to increase cardiac oxygen demand?

A. Halothane
B. Thiopentone
C. Nitrous oxide (N2O)
D. Ketamine (Correct Answer)

Explanation: **Explanation:** **Ketamine (Correct Answer):** Ketamine is a unique anesthetic agent that acts as a **direct sympathomimetic**. It stimulates the sympathetic nervous system, leading to an increase in circulating catecholamines. This results in the "Ketamine Triad": **increased heart rate, increased blood pressure, and increased cardiac output**. These hemodynamic changes significantly elevate **myocardial oxygen demand**. Consequently, Ketamine is generally contraindicated in patients with ischemic heart disease or severe hypertension. **Incorrect Options:** * **Halothane:** This volatile anesthetic is a potent **myocardial depressant**. It decreases cardiac output and blood pressure, thereby reducing myocardial oxygen demand. However, it is high-yield for its tendency to sensitize the myocardium to catecholamines, leading to arrhythmias. * **Thiopentone:** As a barbiturate, it causes peripheral vasodilation and direct myocardial depression. While it may cause a compensatory reflex tachycardia, its overall effect is a reduction in cerebral and systemic metabolic demands. * **Nitrous oxide (N2O):** N2O has a mild direct myocardial depressant effect, which is usually offset by a slight increase in sympathetic tone. However, it does not significantly increase oxygen demand compared to the potent stimulation caused by Ketamine. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Ketamine is the induction agent of choice in **hypovolemic shock** and **cardiac tamponade** due to its pressor effects. * **Exception:** In cases of severe catecholamine depletion (e.g., end-stage heart failure), Ketamine can actually cause a decrease in BP due to its underlying direct myocardial depressant effect being unmasked. * **Key Contraindication:** Avoid Ketamine in patients with **Ischemic Heart Disease (IHD)** and **Raised Intracranial Pressure (ICP)**.

Question 17: Which of the following opioid analgesics is suitable for haemodynamically unstable patients?

A. Morphine
B. Meperidine
C. Fentanyl (Correct Answer)
D. Pentazocine

Explanation: **Explanation:** The primary goal in managing hemodynamically unstable patients is to maintain heart rate, systemic vascular resistance (SVR), and myocardial contractility. **Why Fentanyl is the Correct Choice:** Fentanyl is a synthetic opioid and the preferred analgesic for hemodynamically unstable patients (e.g., trauma, shock, or cardiac surgery) because it is **cardiovascularly stable**. Unlike many other opioids, it **does not cause histamine release**. Consequently, it does not produce the significant peripheral vasodilation or hypotension often seen with morphine. At clinical doses, it has minimal effect on myocardial contractility. **Why Other Options are Incorrect:** * **Morphine:** It triggers significant **histamine release** from mast cells, leading to peripheral vasodilation and a drop in SVR, which can cause profound hypotension in hypovolemic or unstable patients. * **Meperidine (Pethidine):** It has a direct **myocardial depressant** effect and can cause tachycardia (due to its atropine-like structure), which increases myocardial oxygen demand—a risk in unstable patients. * **Pentazocine:** As an agonist-antagonist, it increases pulmonary artery pressure and cardiac workload by increasing catecholamine levels, making it unsuitable for patients with compromised cardiac function. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Fentanyl is the induction agent of choice for cardiac anesthesia and neurosurgery (due to minimal effect on ICP). * **Side Effect:** The most characteristic side effect of rapid high-dose Fentanyl infusion is **Chest Wall Rigidity** (Wooden Chest Syndrome), managed with muscle relaxants. * **Context:** While Fentanyl is stable, it can cause **bradycardia** via central vagal stimulation, but this is generally less detrimental than the hypotension caused by other opioids.

Question 18: What is the recommended ratio of ventilation to cardiac compression in adult CPR when two rescuers are present?

A. 1:15
B. 2:30 (Correct Answer)
C. 30:2
D. 2:10

Explanation: ### Explanation The correct answer is **2:30** (Option B), representing the ratio of **2 breaths to 30 compressions**. **1. Why 2:30 is Correct:** According to the latest **AHA (American Heart Association)** and **ERC (European Resuscitation Council)** guidelines, the universal compression-to-ventilation ratio for **adults** is **30:2**. This applies to both one-rescuer and two-rescuer scenarios. The primary goal is to minimize interruptions in chest compressions to maintain coronary and cerebral perfusion pressure. While the question asks for the "ratio of ventilation to compression," the standard numerical pairing is 2 breaths for every 30 compressions. **2. Why Other Options are Incorrect:** * **A (1:15):** This ratio was used in older guidelines but is no longer recommended for adults. A 15:2 ratio is currently only used in **two-rescuer pediatric/infant CPR**. * **C (30:2):** While 30:2 is the standard *compression-to-ventilation* ratio, the question specifically asks for the ratio of *ventilation to compression*. Therefore, 2:30 is the mathematically accurate response to the phrasing. * **D (2:10):** This ratio is not part of any standard BLS or ACLS protocol. **3. High-Yield Clinical Pearls for NEET-PG:** * **Compression Depth:** 2–2.4 inches (5–6 cm) in adults. * **Compression Rate:** 100–120 per minute. * **Advanced Airway:** Once an endotracheal tube or supraglottic airway is in place, compressions become **continuous**, and ventilations are given at a rate of **1 breath every 6 seconds** (10 breaths/min). * **Recoil:** Allow complete chest recoil after each compression to permit ventricular filling. * **Switching:** Rescuers should switch roles every 2 minutes (or 5 cycles) to prevent fatigue.

Question 19: Which of the following anesthetic agents is safe in patients with heart failure?

A. Etomidate (Correct Answer)
B. Propofol
C. Thiopentone
D. Ketamine

Explanation: **Explanation:** The primary goal in the anesthetic management of heart failure is to maintain hemodynamic stability by avoiding drugs that cause myocardial depression or significant changes in systemic vascular resistance (SVR). **1. Why Etomidate is the Correct Answer:** Etomidate is the induction agent of choice for patients with compromised cardiac function (Heart Failure, Valvular Heart Disease, or Shock). Its unique mechanism involves minimal interference with the sympathetic nervous system and the baroreceptor reflex. It provides **hemodynamic neutrality**, meaning it causes negligible changes in heart rate, stroke volume, and mean arterial pressure. **2. Why the Other Options are Incorrect:** * **Propofol:** It is a potent vasodilator and direct myocardial depressant. It causes a significant drop in SVR and preload, which can lead to severe hypotension in heart failure patients. * **Thiopentone:** Like other barbiturates, it causes dose-dependent peripheral vasodilation and negative inotropy, leading to a decrease in cardiac output. * **Ketamine:** While it stimulates the sympathetic nervous system (increasing HR and BP), it is a **direct myocardial depressant**. In patients with end-stage heart failure who are already "catecholamine-depleted," the stimulatory effect is lost, and the direct depressant effect can lead to cardiovascular collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Etomidate Side Effect:** Adrenocortical suppression (inhibits 11-beta-hydroxylase). Avoid in septic shock. * **Drug of Choice for Hemodynamic Stability:** Etomidate. * **Drug of Choice for Reactive Airway Disease:** Ketamine (Bronchodilator). * **Drug of Choice for Day Care Surgery:** Propofol (Rapid recovery).

Question 20: For the management of intraoperative myocardial ischemia, all of the following are advised except?

A. Heparin (Correct Answer)
B. Intravenous nitroglycerine
C. Calcium channel blocker
D. Atropine

Explanation: **Explanation:** The primary goal in managing **intraoperative myocardial ischemia** is to restore the balance between myocardial oxygen supply and demand. This is achieved by manipulating hemodynamic parameters (heart rate, blood pressure, and preload). **Why Heparin is the Correct Answer (The "Except"):** While Heparin is a cornerstone in the management of *Acute Coronary Syndrome (ACS)* in the ER or ICU, it is **not** a primary treatment for intraoperative ischemia. In the operating room, ischemia is usually "demand-led" (due to tachycardia or hypertension) rather than "supply-led" (due to acute plaque rupture and thrombosis). Administering heparin intraoperatively carries a significant risk of surgical site hemorrhage without addressing the immediate hemodynamic triggers of the ischemia. **Analysis of Incorrect Options:** * **Intravenous Nitroglycerine (NTG):** The first-line treatment. It causes venodilation, which decreases preload and ventricular wall tension, thereby reducing oxygen demand. It also dilates coronary arteries to improve supply. * **Calcium Channel Blockers (CCBs):** Agents like Diltiazem are used to control heart rate and reduce systemic vascular resistance, helping to balance the oxygen equation, especially if beta-blockers are contraindicated. * **Atropine:** While Atropine increases heart rate (which usually worsens ischemia), it is indicated if the ischemia is triggered by **severe bradycardia**, which leads to low cardiac output and reduced coronary perfusion pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Most sensitive monitor:** Transesophageal Echocardiography (TEE) is more sensitive than ECG for detecting wall motion abnormalities (the earliest sign of ischemia). * **ECG Lead:** Lead **V5** is the most sensitive single lead for detecting ischemia (75% sensitivity), while combining **V4, V5, and Lead II** increases sensitivity to >95%. * **Management Priority:** The first step is always to increase oxygen delivery (FiO2 100%) and normalize hemodynamics (Target: Slow, Small, Regular heart).

Question 21: During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which of the following anesthetic agents, administered prior to circulatory arrest, also provides cerebral protection?

A. Etomidate
B. Thiopental Sodium (Correct Answer)
C. Propofol
D. Ketamine

Explanation: ### **Explanation** **Correct Option: B. Thiopental Sodium** **Mechanism of Cerebral Protection:** During Deep Hypothermic Circulatory Arrest (DHCA), the brain is at high risk of ischemic injury. **Thiopental Sodium** (a barbiturate) provides cerebral protection primarily by **decreasing the Cerebral Metabolic Rate of Oxygen (CMRO₂)**. It suppresses neuronal electrical activity (burst suppression on EEG), thereby reducing the oxygen demand of the brain. By lowering the metabolic rate, it extends the brain's tolerance to periods of zero or low perfusion. Additionally, it helps in scavenging free radicals and reducing intracranial pressure (ICP). **Why Other Options are Incorrect:** * **A. Etomidate:** While etomidate reduces CMRO₂ and ICP, it is generally avoided in major cardiac/vascular surgeries due to its side effect of **adrenocortical suppression**, which can impair the stress response required during such high-risk procedures. * **C. Propofol:** Propofol does reduce CMRO₂; however, it is not the traditional "gold standard" for DHCA compared to Thiopental. Furthermore, its profound **vasodilatory and hypotensive effects** can be disadvantageous during the induction of deep hypothermia. * **D. Ketamine:** Ketamine is generally contraindicated for cerebral protection as it traditionally **increases CMRO₂, cerebral blood flow, and ICP**, potentially worsening neuronal outcomes during ischemia. --- ### **High-Yield Clinical Pearls for NEET-PG** * **Gold Standard for DHCA:** Thiopental is the classic induction agent used to achieve "burst suppression" on EEG before circulatory arrest. * **Temperature Factor:** Hypothermia is the **most potent** method of cerebral protection (CMRO₂ decreases by ~7% for every 1°C drop in temperature). * **Barbiturate Effect:** Barbiturates only reduce the *functional* metabolic activity of the brain; they do not affect the *basal* metabolic rate (cell maintenance). * **Inhalational Agents:** Isoflurane also provides some cerebral protection by reducing CMRO₂, but Thiopental remains the preferred pharmacological adjunct for circulatory arrest.

Question 22: In a patient with severe aortic stenosis, which of the following anesthetic techniques is least preferred?

A. Propofol induction
B. Etomidate induction
C. Spinal anesthesia with 15 mg bupivacaine (Correct Answer)
D. Epidural anesthesia with 2% lidocaine

Explanation: In **Severe Aortic Stenosis (AS)**, the cardiac output is "fixed" due to the narrowed valve. The hemodynamic goals are to maintain **Normal Sinus Rhythm**, **High-Normal Afterload (SVR)**, and **Adequate Preload**. ### Why Spinal Anesthesia is Least Preferred Spinal anesthesia (Option C) is generally **contraindicated** in severe AS. A dose of 15 mg bupivacaine typically results in a rapid, dense sympathetic blockade. This causes a sudden, profound drop in **Systemic Vascular Resistance (SVR)**. Because the stenotic valve limits the increase in cardiac output, the body cannot compensate for this hypotension. This leads to decreased coronary perfusion pressure, myocardial ischemia, and potentially fatal cardiac arrest. ### Analysis of Other Options * **A. Propofol induction:** While propofol causes vasodilation and myocardial depression, it can be used with extreme caution and slow titration. However, it is less dangerous than the rapid onset of a high-level spinal block. * **B. Etomidate induction:** This is often the **induction agent of choice** for AS because it is cardiostable and maintains SVR and heart rate. * **D. Epidural anesthesia:** Unlike spinal anesthesia, an epidural allows for a **gradual, titrated** onset of sympathetic block. With careful dosing, SVR can be maintained more effectively than with a "single-shot" spinal. ### High-Yield Clinical Pearls for NEET-PG * **The "Death Spiral" of AS:** Hypotension → Decreased Coronary Perfusion → Myocardial Ischemia → Decreased Contractility → Further Hypotension. * **Heart Rate Goal:** Maintain a slow-to-normal heart rate (60–80 bpm). Tachycardia is poorly tolerated as it decreases diastolic filling time and increases oxygen demand. * **Atrial Kick:** Maintenance of Sinus Rhythm is vital; the "atrial kick" contributes up to 40% of stroke volume in AS patients. * **Vasopressor of Choice:** Phenylephrine (increases SVR without increasing heart rate).

Question 23: Which of the following induction agents produces cardiac stability in patients with coronary artery disease?

A. Ketamine
B. Etomidate (Correct Answer)
C. Propofol
D. Midazolam

Explanation: **Explanation:** **Etomidate** is the induction agent of choice for patients with coronary artery disease (CAD) or compromised cardiovascular reserve because it provides the greatest **hemodynamic stability**. It has minimal to no effect on heart rate, mean arterial pressure, or cardiac output. Crucially, it maintains the balance between myocardial oxygen supply and demand, making it ideal for patients where tachycardia or hypotension could trigger ischemia. **Analysis of Incorrect Options:** * **Ketamine (A):** It is a direct myocardial depressant but acts as a **sympathomimetic** by inhibiting catecholamine reuptake. This leads to increased heart rate, blood pressure, and myocardial oxygen consumption, which can precipitate angina or myocardial infarction in CAD patients. * **Propofol (C):** It causes significant **hypotension** due to profound vasodilation (decreased systemic vascular resistance) and direct myocardial depression. This drop in perfusion pressure can compromise coronary blood flow. * **Midazolam (D):** While relatively safe, it can cause a modest decrease in systemic vascular resistance and blood pressure, especially when combined with opioids. It is not as "cardio-stable" as Etomidate. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Etomidate acts via the GABA-A receptor. * **Major Side Effect:** **Adrenocortical suppression** (inhibits 11-beta-hydroxylase), which is its most tested disadvantage. * **Myoclonus:** Common during induction with Etomidate (can be reduced by pre-treatment with opioids). * **Drug of Choice:** For patients with shock, trauma, or severe valvular heart disease.

Question 24: Which of the following is most cardiostable?

A. Thiopentone sodium
B. Ketamine
C. Propofol
D. Etomidate (Correct Answer)

Explanation: ### Explanation **Etomidate** is considered the most cardiostable intravenous induction agent because it has minimal to no effect on myocardial contractility, heart rate, or cardiac output. #### Why Etomidate is the Correct Answer: The primary reason for its stability is its lack of interference with the **autonomic nervous system** and its minimal effect on **baroreceptor reflex** mechanisms. It does not cause histamine release and maintains stable systemic vascular resistance (SVR). This makes it the "gold standard" for induction in patients with compromised cardiac function, such as those with valvular heart disease, congestive heart failure, or severe coronary artery disease. #### Why Other Options are Incorrect: * **Thiopentone Sodium:** A potent venodilator that causes a significant drop in blood pressure due to peripheral pooling of blood and direct myocardial depression. It is contraindicated in hypovolemic or shock states. * **Ketamine:** While it often maintains BP, it is not "stable" in the physiological sense. It is **sympathomimetic**, causing an increase in heart rate, BP, and myocardial oxygen demand. In a failing heart with depleted catecholamines, it can actually act as a direct myocardial depressant. * **Propofol:** Known for causing the most significant drop in blood pressure among induction agents. It causes profound vasodilation (both arterial and venous) and inhibits the baroreceptor reflex, preventing a compensatory tachycardia. #### High-Yield Clinical Pearls for NEET-PG: * **Adrenal Suppression:** The major side effect of Etomidate is dose-dependent inhibition of **11-beta-hydroxylase**, leading to suppressed cortisol synthesis (caution in sepsis). * **Myoclonus:** Etomidate is frequently associated with excitatory movements (myoclonus) during induction. * **Drug of Choice:** Etomidate is the preferred agent for **Rapid Sequence Induction (RSI)** in hemodynamically unstable patients. * **Propofol** is the drug of choice for day-care surgery due to its rapid metabolism and anti-emetic properties.

Question 25: The best chances of recovery after successful cardiopulmonary resuscitation are seen in which cardiac rhythm?

A. Ventricular Tachycardia (Correct Answer)
B. Ventricular Fibrillation
C. Asystole
D. Electromechanical dissociation

Explanation: **Explanation:** The prognosis of cardiac arrest is heavily dependent on the initial presenting rhythm. **Ventricular Tachycardia (VT)**, specifically pulseless VT, carries the best prognosis for recovery and neurologically intact survival. **Why Ventricular Tachycardia is the correct answer:** VT and Ventricular Fibrillation (VF) are "shockable" rhythms. However, VT represents a more organized electrical activity than VF. In VT, the myocardium often retains better metabolic status and a higher likelihood of returning to a perfusing rhythm (ROSC) immediately following defibrillation. Because the heart is often in a "fresher" state of ischemia compared to other rhythms, the chances of successful resuscitation are highest. **Analysis of Incorrect Options:** * **Ventricular Fibrillation (VF):** While also a shockable rhythm with a good prognosis compared to non-shockable rhythms, it represents chaotic electrical activity. The longer a patient stays in VF, the more myocardial energy stores are depleted, eventually deteriorating into asystole. * **Asystole:** This is a "non-shockable" rhythm representing the total absence of electrical and mechanical activity. It usually signifies a prolonged period of ischemia and has the poorest prognosis. * **Electromechanical Dissociation (PEA):** In Pulseless Electrical Activity, there is organized electrical activity but no mechanical contraction. It is often caused by reversible factors (the H’s and T’s), but the survival rates are significantly lower than shockable rhythms like VT. **High-Yield Clinical Pearls for NEET-PG:** * **Chain of Survival:** The most critical factor in VT/VF survival is the **time to defibrillation**. * **Shockable Rhythms:** VT and VF. * **Non-Shockable Rhythms:** Asystole and PEA. * **Drug of Choice:** Epinephrine is the primary vasopressor used in all cardiac arrests; Amiodarone or Lidocaine are used specifically for refractory VT/VF.

Question 26: According to the 2010 ACLS Guidelines by AHA, which of the following pharmacological agents is not used in the management of cardiac arrest?

A. Epinephrine
B. Vasopressin
C. Atropine (Correct Answer)
D. Amiodarone

Explanation: **Explanation:** The correct answer is **Atropine**. According to the 2010 AHA ACLS Guidelines, Atropine was officially removed from the Cardiac Arrest Algorithm. **Why Atropine is the correct answer:** Previously, Atropine was used for Pulseless Electrical Activity (PEA) and Asystole. However, clinical evidence demonstrated that its routine use during cardiac arrest does not improve outcomes or survival to hospital discharge. While Atropine remains a first-line drug for **symptomatic bradycardia** (with a pulse), it is no longer indicated for a patient in active cardiac arrest. **Analysis of Incorrect Options:** * **Epinephrine (Option A):** This remains the primary vasopressor used in all cardiac arrest rhythms (VF/pVT, PEA, and Asystole). It is administered every 3–5 minutes to improve coronary and cerebral perfusion pressure via its alpha-adrenergic effects. * **Vasopressin (Option B):** In the 2010 guidelines, a single dose of Vasopressin (40 units IV/IO) was permitted as a substitute for the first or second dose of Epinephrine. (Note: It was later removed in the 2015 update to simplify the algorithm). * **Amiodarone (Option C):** This is the preferred anti-arrhythmic agent for shock-refractory Ventricular Fibrillation (VF) or pulseless Ventricular Tachycardia (pVT). **High-Yield Clinical Pearls for NEET-PG:** * **Asystole/PEA:** The only drugs indicated are Epinephrine and treating reversible causes (H’s and T’s). * **Shockable Rhythms (VF/pVT):** If shocks and Epinephrine fail, use Amiodarone (300mg bolus) or Lidocaine. * **Atropine Dosage:** For symptomatic bradycardia, the dose is 1 mg IV every 3–5 minutes (Max: 3 mg). * **Magnesium Sulfate:** Only indicated during cardiac arrest if **Torsades de Pointes** is suspected.

Question 27: A 40-year-old lady intraoperatively develops a heart rate of 220 bpm and a blood pressure of 70/40 mmHg. The ECG shows a QRS complex of 120 milliseconds. What is the best management?

A. Adenosine 6 mg/12 mg
B. Amiodarone
C. DC cardioversion (Correct Answer)
D. Esmolol

Explanation: ### Explanation The core principle in managing any perioperative tachyarrhythmia is assessing **hemodynamic stability**. **1. Why DC Cardioversion is Correct:** The patient is presenting with **unstable tachycardia**, evidenced by a heart rate of 220 bpm and significant hypotension (BP 70/40 mmHg). According to ACLS guidelines, any patient with a tachyarrhythmia (narrow or wide complex) who shows signs of "shock" or hemodynamic instability (hypotension, altered mental status, chest pain, or acute heart failure) must be treated immediately with **synchronized DC cardioversion**. In this case, the QRS duration of 120 ms (borderline wide) suggests a ventricular origin or SVT with aberrancy, but the instability makes electrical therapy the first-line priority over pharmacological intervention. **2. Why Other Options are Incorrect:** * **Adenosine:** This is the drug of choice for *stable* Narrow Complex Supraventricular Tachycardia (SVT). It is contraindicated here because the patient is hypotensive; delaying cardioversion to attempt chemical conversion increases the risk of cardiac arrest. * **Amiodarone:** This is used for *stable* Wide Complex Tachycardia (Ventricular Tachycardia). While effective, it takes time to work and is inappropriate for an unstable patient. * **Esmolol:** A short-acting beta-blocker used for rate control in stable atrial fibrillation or flutter. It has negative inotropic properties which would further worsen this patient's hypotension. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Thumb":** If the patient is **Unstable → Shock** (Synchronized Cardioversion). If the patient is **Stable → Medicate**. * **QRS Width:** Narrow (<120 ms) usually implies supraventricular origin; Wide (≥120 ms) usually implies ventricular origin. * **Synchronized vs. Unsynchronized:** Always use *synchronized* shocks for patients with a pulse (to avoid the R-on-T phenomenon and VF). Use *unsynchronized* (defibrillation) for pulseless VT or VF.

Question 28: What is the most common arrhythmia after sinus tachycardia in an ICU patient?

A. Atrial flutter (Correct Answer)
B. A-V block
C. Non-paroxysmal junctional tachycardia
D. Paroxysmal supraventricular tachycardia

Explanation: **Explanation:** In the Intensive Care Unit (ICU) setting, the most frequent rhythm disturbance encountered is **Sinus Tachycardia**, which is usually a physiological response to stress, pain, fever, or hypovolemia. However, when considering pathological supraventricular arrhythmias, **Atrial Flutter** is statistically the most common arrhythmia following sinus tachycardia in critically ill patients. **Why Atrial Flutter is correct:** Atrial flutter is frequently triggered in the ICU due to acute factors such as pulmonary embolism, electrolyte imbalances, acid-base disturbances, or cardiac surgery. It is characterized by a "saw-tooth" pattern on ECG and often presents with a fixed or variable AV block (commonly 2:1). Its high prevalence in the ICU is linked to the high adrenergic state and atrial stretch seen in critically ill patients. **Analysis of Incorrect Options:** * **A-V Block:** While common in patients with myocardial infarction or drug toxicity (e.g., Digoxin), it is a conduction defect rather than a primary tachyarrhythmia and occurs less frequently than atrial flutter in general ICU populations. * **Non-paroxysmal junctional tachycardia:** This is a rare arrhythmia typically associated with digitalis toxicity or post-cardiac surgery in pediatric patients; it is not a common finding in a general adult ICU. * **Paroxysmal Supraventricular Tachycardia (PSVT):** While common in the general population (often due to AVNRT), it occurs less frequently in the acute ICU setting compared to atrial flutter or atrial fibrillation. **High-Yield Clinical Pearls for NEET-PG:** * **Most common arrhythmia overall:** Sinus Tachycardia. * **Most common sustained arrhythmia in the elderly/ICU:** Atrial Fibrillation (Note: If Atrial Fibrillation is not an option, Atrial Flutter is the prioritized answer). * **Drug of choice for hemodynamically stable PSVT:** Adenosine. * **Treatment of choice for unstable Atrial Flutter:** Synchronized Cardioversion.

Question 29: During the surgical removal of an invasive glioma from the base of the skull, cranial nerves IX and X are accidentally cut bilaterally. What would be the immediate change in the patient's hemodynamic condition?

A. Bradycardia with hypertension
B. Bradycardia with hypotension
C. Sinus arrhythmia with hypotension
D. Tachycardia with hypertension (Correct Answer)

Explanation: **Explanation:** The correct answer is **Tachycardia with hypertension** because of the interruption of the **Baroreceptor Reflex** arc. **The Underlying Concept:** The baroreceptors (located in the carotid sinus and aortic arch) are responsible for sensing blood pressure changes and sending inhibitory signals to the vasomotor center in the medulla. * **Afferent Pathway:** The Glossopharyngeal nerve (**CN IX**) carries signals from the carotid sinus, and the Vagus nerve (**CN X**) carries signals from the aortic arch. * **Physiology:** Under normal conditions, these nerves provide tonic inhibition to the sympathetic nervous system. When both CN IX and CN X are cut bilaterally, the brain perceives an "acute loss of pressure" (pseudo-hypotension). This results in the immediate withdrawal of parasympathetic tone and a massive, unopposed **sympathetic surge**, leading to an immediate rise in heart rate (tachycardia) and systemic vascular resistance (hypertension). **Analysis of Incorrect Options:** * **A & B (Bradycardia):** Cutting the Vagus nerve (the primary parasympathetic supply to the heart) removes the "vagal brake," making bradycardia physiologically impossible in this scenario. * **C (Hypotension):** Hypotension would only occur if the sympathetic outflow were blocked. Here, the "off-switch" for the sympathetic system is destroyed, leading to the opposite effect. **High-Yield Clinical Pearls for NEET-PG:** 1. **The Reflex Arc:** Remember: **S**inus (Carotid) → **G**lossopharyngeal (IX) and **A**rch (Aortic) → **V**agus (X). (Mnemonic: **SGA-V**) 2. **Surgical Context:** Bilateral injury is rare but most common in extensive skull base surgeries or radical neck dissections. 3. **Vagal Stimulation vs. Vagal Section:** Stimulation of CN X (e.g., traction on viscera) causes bradycardia; sectioning/cutting CN X causes tachycardia. 4. **Cushing’s Triad:** Do not confuse this with the Cushing reflex (Hypertension + Bradycardia), which is caused by *increased intracranial pressure*, not direct nerve transection.

Question 30: What is the vasopressor of choice in anesthesia for a patient with aortic stenosis who develops hypotension during surgery?

A. Ephedrine
B. Dopamine
C. Dobutamine
D. Phenylephrine (Correct Answer)

Explanation: **Explanation:** The primary hemodynamic goal in managing a patient with **Aortic Stenosis (AS)** is to maintain a "slow, small, and tight" profile. This means maintaining a normal sinus rhythm, adequate preload, and **high systemic vascular resistance (SVR)**. **Why Phenylephrine is the Correct Choice:** In AS, the left ventricle (LV) is hypertrophied and highly dependent on coronary perfusion pressure to meet its high oxygen demands. Coronary perfusion pressure is determined by the gradient between the aortic diastolic pressure and the LV end-diastolic pressure. **Phenylephrine**, a pure alpha-1 agonist, increases SVR and aortic diastolic pressure without increasing the heart rate. This maintains coronary perfusion while avoiding tachycardia, which is detrimental in AS because it shortens diastole (reducing coronary filling time) and increases myocardial oxygen demand. **Why the Other Options are Incorrect:** * **Ephedrine:** This is a sympathomimetic with both alpha and beta activity. Its beta-1 effect causes tachycardia, which decreases diastolic filling time and increases myocardial oxygen consumption, potentially leading to ischemia in a stenotic heart. * **Dobutamine:** A potent beta-1 agonist (inodilator). It increases heart rate and decreases SVR, both of which are contraindicated in severe AS as they can lead to a precipitous drop in coronary perfusion. * **Dopamine:** At medium to high doses, it increases heart rate and myocardial contractility. Similar to ephedrine, the risk of tachycardia makes it less ideal than a pure alpha agonist. **High-Yield Clinical Pearls for NEET-PG:** * **AS Hemodynamic Goals:** Maintain Preload (High), SVR (High), Heart Rate (Low/Normal 60-80 bpm), and Sinus Rhythm (Crucial for atrial kick, which contributes up to 40% of LV filling in AS). * **Avoid:** Tachycardia, Bradycardia, and Vasodilation (Spinal anesthesia is generally avoided or used with extreme caution due to rapid sympathectomy). * **Fixed Cardiac Output:** AS is a fixed-output state; the heart cannot increase stroke volume in response to vasodilation.

Question 31: After effective cardiopulmonary resuscitation, what physiological change is observed?

A. Constriction of pupil (Correct Answer)
B. Dilation of pupil
C. Elevation of blood pressure
D. None of the above

Explanation: **Explanation:** The primary goal of cardiopulmonary resuscitation (CPR) is to restore the delivery of oxygenated blood to vital organs, most importantly the brain. The pupillary response is a critical clinical indicator of cerebral perfusion and brainstem function during and after resuscitation. **Why Option A is Correct:** During cardiac arrest, the lack of blood flow to the brain leads to cerebral hypoxia, causing the pupils to become fixed and dilated (mydriasis) due to the loss of parasympathetic tone. **Effective CPR** restores oxygenated blood flow to the Edinger-Westphal nucleus in the midbrain. When cerebral perfusion is adequate, the parasympathetic nervous system reactivates, leading to **pupillary constriction (miosis)**. This is often the first clinical sign that resuscitative efforts are providing sufficient cardiac output to maintain brain viability. **Why Other Options are Incorrect:** * **Option B (Dilation):** Mydriasis is a sign of sympathetic overactivity or, more commonly in this context, severe cerebral hypoxia/ischemia. Persistent dilation during CPR suggests poor prognosis or inadequate chest compressions. * **Option C (Elevation of BP):** While effective CPR generates a pulse and some blood pressure, "elevation" of blood pressure (hypertension) is not a standard physiological hallmark of the resuscitation process itself. Blood pressure remains significantly lower than baseline during manual compressions. **High-Yield Clinical Pearls for NEET-PG:** * **Pupillary reflex:** The most sensitive indicator of the adequacy of cerebral circulation during CPR. * **End-Tidal CO2 (EtCO2):** The most reliable *monitor* for CPR quality. A sudden increase in EtCO2 (to >35-40 mmHg) is the earliest sign of **ROSC** (Return of Spontaneous Circulation). * **Compression Depth:** 5–6 cm in adults at a rate of 100–120 bpm. * **Epinephrine:** Administered to increase coronary perfusion pressure via alpha-1 mediated vasoconstriction.

Question 32: What is the anesthetic of choice for cardiac anesthesia?

A. Isoflurane (Correct Answer)
B. Ketamine
C. Methoxyflurane
D. Halothane

Explanation: **Explanation:** **Isoflurane (Option A)** is considered the anesthetic of choice for cardiac anesthesia among the given options due to its favorable hemodynamic profile. Its primary advantage is the **preservation of cardiac output** and its unique property of **"Ischemic Preconditioning,"** which protects the myocardium against ischemic injury. While it causes a decrease in systemic vascular resistance (SVR) leading to a drop in blood pressure, it does not significantly depress myocardial contractility compared to older agents. Furthermore, it is less likely to sensitize the myocardium to catecholamines. **Why other options are incorrect:** * **Ketamine (Option B):** While often used in hemodynamically unstable patients, it is generally avoided in patients with coronary artery disease (CAD) because it increases sympathetic outflow, leading to tachycardia and hypertension, which significantly increases myocardial oxygen demand. * **Methoxyflurane (Option C):** It is highly nephrotoxic due to the release of inorganic fluoride ions and has a very slow onset/offset, making it obsolete in modern cardiac anesthesia. * **Halothane (Option D):** It is a potent myocardial depressant and sensitizes the myocardium to endogenous and exogenous catecholamines, increasing the risk of fatal ventricular arrhythmias. It also lacks the protective preconditioning effects of isoflurane. **High-Yield Clinical Pearls for NEET-PG:** * **Coronary Steal Phenomenon:** Historically associated with Isoflurane (potent coronary vasodilator), but clinically insignificant at standard anesthetic doses (0.5–1.5 MAC). * **Sevoflurane vs. Isoflurane:** Sevoflurane is also widely used due to its rapid onset and lack of airway irritability, but Isoflurane remains a classic "textbook" answer for its stability and cost-effectiveness. * **Etomidate:** Often the induction agent of choice for cardiac surgery due to its superior hemodynamic stability.

Question 33: What is true regarding cardiopulmonary resuscitation?

A. The most common presentation in ECG is asystole.
B. The compression to ventilation ratio is 5:1.
C. Adrenaline is given if cardioversion fails. (Correct Answer)
D. Calcium gluconate is given immediately.

Explanation: ### Explanation **Correct Option: C. Adrenaline is given if cardioversion fails.** In the management of **Shockable Rhythms** (Ventricular Fibrillation/Pulseless Ventricular Tachycardia), the priority is immediate defibrillation. If the initial shocks fail to restore a perfusing rhythm, **Adrenaline (1 mg IV/IO)** is administered. According to ACLS guidelines, adrenaline is typically given after the second shock and then every 3–5 minutes. It acts via alpha-1 adrenergic receptors to cause vasoconstriction, increasing coronary and cerebral perfusion pressure during CPR. **Why the other options are incorrect:** * **A. The most common presentation in ECG is asystole:** In the context of sudden adult cardiac arrest (especially out-of-hospital), the most common initial rhythm is actually **Ventricular Fibrillation (VF)**. Asystole is more common in pediatric arrests or as a terminal rhythm after prolonged untreated VF. * **B. The compression to ventilation ratio is 5:1:** For adult basic life support (BLS), the universal ratio for one or two rescuers is **30:2**. The 5:1 ratio is outdated and no longer used in standard adult or pediatric resuscitation. * **C. Calcium gluconate is given immediately:** Calcium is **not** recommended for routine use in cardiac arrest. It is only indicated in specific scenarios: hyperkalemia, hypocalcemia, or calcium channel blocker toxicity. Routine use may worsen neurological outcomes due to intracellular calcium overload. **High-Yield Clinical Pearls for NEET-PG:** * **Compression Depth:** 2–2.4 inches (5–6 cm) in adults. * **Compression Rate:** 100–120 per minute. * **Amiodarone:** The anti-arrhythmic of choice for refractory VF/pVT, given after the third shock (300 mg bolus). * **H's and T's:** Always screen for reversible causes (Hypovolemia, Hypoxia, Hydrogen ion/Acidosis, Hypo/Hyperkalemia, Hypothermia; Tension pneumothorax, Tamponade, Toxins, Thrombosis).

Question 34: What is true regarding cardiopulmonary resuscitation?

A. The most common presentation in ECG is asystole.
B. The compression to ventilation ratio is 5:1.
C. Adrenaline is given if cardioversion fails. (Correct Answer)
D. Calcium gluconate is given immediately.

Explanation: In Cardiopulmonary Resuscitation (CPR), the management of cardiac arrest follows the Advanced Cardiovascular Life Support (ACLS) guidelines. **Explanation of the Correct Option:** **Option C** is correct because in cases of shockable rhythms (Ventricular Fibrillation or Pulseless Ventricular Tachycardia), the priority is defibrillation. If the initial shocks (cardioversion/defibrillation) fail to restore a perfusing rhythm, **Adrenaline (1 mg every 3–5 minutes)** is administered to improve coronary and cerebral perfusion pressure via its alpha-adrenergic vasoconstrictive effects. **Analysis of Incorrect Options:** * **Option A:** The most common initial rhythm in out-of-hospital cardiac arrest (OHCA) is **Ventricular Fibrillation (VF)**, not asystole. Asystole is often a late finding with a poorer prognosis. * **Option B:** According to current AHA guidelines, the universal compression-to-ventilation ratio for adults is **30:2**. A 5:1 ratio is obsolete and no longer recommended. * **Option D:** Calcium gluconate is **not** given routinely. It is only indicated in specific scenarios: hyperkalemia, hypocalcemia, or magnesium toxicity/calcium channel blocker overdose. Routine use can cause cerebral reperfusion injury. **High-Yield Clinical Pearls for NEET-PG:** * **Compression Depth:** 2–2.4 inches (5–6 cm) at a rate of 100–120 bpm. * **Shockable Rhythms:** VF and Pulseless VT. * **Non-Shockable Rhythms:** Asystole and PEA (Pulseless Electrical Activity). * **Amiodarone:** The first-line anti-arrhythmic (300mg bolus) given if VF/pVT persists after the 3rd shock. * **H's and T's:** Always look for reversible causes (Hypoxia, Hypovolemia, Hydrogen ion/Acidosis, Hypo/Hyperkalemia, Hypothermia; Tension pneumothorax, Tamponade, Toxins, Thrombosis).

Question 35: During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which of the following anesthetic agents administered prior to circulatory arrest also provides cerebral protection?

A. Etomidate
B. Thiopental Sodium (Correct Answer)
C. Propofol
D. Ketamine

Explanation: **Explanation:** The primary goal during Deep Hypothermic Circulatory Arrest (DHCA) is to minimize the brain's metabolic demand to prevent ischemic injury. **Why Thiopental Sodium is Correct:** Thiopental sodium is the classic "gold standard" for pharmacological cerebral protection during cardiac surgery. It works by causing **dose-dependent suppression of cerebral metabolic rate for oxygen (CMRO2)**. It reduces neuronal electrical activity until the EEG becomes isoelectric (burst suppression), thereby decreasing the oxygen requirement of the brain. Additionally, it provides protection by stabilizing lysosomal membranes and scavenging free radicals. In clinical practice, it is often administered as a bolus or infusion just prior to the initiation of circulatory arrest to provide a "safety buffer" alongside hypothermia. **Why Other Options are Incorrect:** * **Etomidate:** While it reduces CMRO2 and intracranial pressure, it is generally avoided in major cardiac surgeries due to its known side effect of **adrenocortical suppression**, which can impair the stress response required during complex aortic repairs. * **Propofol:** Propofol does reduce CMRO2 similarly to Thiopental; however, it causes significant **systemic vasodilation and myocardial depression**, which can lead to hemodynamic instability during the critical transition to cardiopulmonary bypass. Thiopental remains the more traditionally cited answer for "cerebral protection" in exam contexts. * **Ketamine:** This is contraindicated for cerebral protection as it typically **increases CMRO2**, cerebral blood flow, and intracranial pressure, potentially worsening the balance between oxygen supply and demand. **High-Yield Pearls for NEET-PG:** * **Hypothermia** is the most effective method of cerebral protection (CMRO2 decreases by ~7% for every 1°C drop in temperature). * **Thiopental** only reduces the *functional* component of CMRO2; it cannot reduce the *basal* metabolic rate required for cellular integrity. * **Barbiturate Coma:** Thiopental is also used for refractory intracranial hypertension. * **Target Temperature in DHCA:** Usually 18°C–22°C.

Question 36: All are correct about the pressure recording shown below except: (Recent NEET Pattern 2016-17)

A. Normal CVP is 2-10 cm of water
B. Pressure recording of more than 10 cm of water implies restricting IV fluids to the patient
C. Venous catheter is advanced into subclavicular IVC
D. Can be used to assess left ventricular function (Correct Answer)

Explanation: ***Can be used to assess left ventricular function*** - Central venous pressure (CVP) primarily reflects **right atrial pressure** and, indirectly, **right ventricular end-diastolic pressure**. - It is **not a reliable indicator** for assessing **left ventricular function**, which is better gauged by pulmonary artery wedge pressure (PAWP) or echocardiography. *Normal CVP is 2-10 cm of water* - The image depicts a manometer measuring CVP in **cm of water**. - The generally accepted normal range for CVP is **2-10 cm H2O** (or 0-8 mmHg), reflecting adequate right heart filling and venous return. *Pressure recording of more than 10 cm of water implies restricting IV fluids to the patient* - A CVP **above 10 cm H2O** (or 8 mmHg) typically indicates **fluid overload**, increased right ventricular preload, or right ventricular dysfunction. - In such cases, **restricting intravenous fluids** is often appropriate to prevent further circulatory congestion and potential complications like pulmonary edema. *Venous catheter is advanced into subclavicular IVC* - For CVP measurement, the catheter tip should ideally be positioned in the **superior vena cava (SVC)**, near its junction with the **right atrium**. - Advancing the catheter into the **inferior vena cava (IVC)** is anatomically incorrect for standard CVP measurement, as it would not reflect right atrial pressure as directly or accurately.

Question 37: Most sensitive method of monitoring cardiovascular ischemia in the perioperative period is -

A. NIBP
B. ECG
C. Pulse oximeter
D. TEE (Correct Answer)

Explanation: ***TEE*** - **Transesophageal echocardiography (TEE)** is the most sensitive method for detecting perioperative myocardial ischemia because it can visualize **regional wall motion abnormalities** and changes in **ventricular function** much earlier than ECG. - **Ischemia** directly impairs the contractility of the affected myocardium, leading to subtle changes in wall motion that TEE can identify. *NIBP* - **Non-invasive blood pressure (NIBP)** monitoring can detect **hemodynamic changes** (like hypotension or hypertension) that may precede or accompany ischemia. - However, these changes are **non-specific** and occur relatively late, making NIBP a less sensitive indicator of early ischemia. *ECG* - **Electrocardiography (ECG)** monitors the electrical activity of the heart and can detect **ST-segment changes** indicative of ischemia. - While useful, ECG changes may appear later than wall motion abnormalities, and **silent ischemia** can be missed if the leads are not optimally placed or if the ischemia does not produce significant electrical changes. *Pulse oximeter* - A **pulse oximeter** measures **oxygen saturation** in the peripheral blood. - It is primarily used to assess **respiratory function** and tissue oxygenation, and it does not directly monitor myocardial ischemia or cardiac function.

Question 38: Which of the following is not used in controlling heart rate intraoperatively?

A. Verapamil
B. Esmolol
C. Propanolol/Metoprolol
D. Procainamide (Correct Answer)

Explanation: ***Procainamide*** - While an antiarrhythmic, **procainamide** is primarily used for the treatment of various *atrial* and *ventricular arrhythmias* and *Wolff-Parkinson-White syndrome*, not for heart rate control alone. - Its mechanism involves blocking sodium channels and some potassium channels, affecting myocardial excitability and conduction. *Verapamil* - **Verapamil** is a **non-dihydropyridine calcium channel blocker** frequently used intraoperatively to **slow heart rate** by acting on the sinoatrial and atrioventricular nodes. - It is effective in treating *supraventricular tachycardias* (SVT) and controlling ventricular rate in *atrial fibrillation* or *flutter*. *Esmolol* - **Esmolol** is a **short-acting, cardioselective beta-1 adrenergic blocker** that is often administered intraoperatively due to its rapid onset and offset of action. - It is used to quickly **decrease heart rate** and blood pressure, particularly in response to surgical stress or in cases of *supraventricular tachycardia*. *Propranolol/Metoprolol* - **Propranolol** (non-selective) and **Metoprolol** (cardioselective) are **beta-adrenergic blockers** commonly used to **reduce heart rate** and myocardial oxygen demand. - They are effective in managing *tachycardia*, *hypertension*, and preventing *myocardial ischemia* during surgery.

Question 39: A patient with history of coronary artery disease presents with pulse rate of 48/min and low BP. Patient has decreased myocardial contractility on Echo. Which of these anesthetic agents is contraindicated?

A. Fentanyl
B. Etomidate
C. Ketamine
D. Dexmedetomidine (Correct Answer)

Explanation: ***Dexmedetomidine*** - Dexmedetomidine is a **highly selective alpha-2 adrenergic agonist** that causes a dose-dependent decrease in heart rate and blood pressure, which would exacerbate the patient's existing **bradycardia** and **hypotension**. - Its negative chronotropic and inotropic effects make it contraindicated in patients with compromised cardiac function and already low heart rate and blood pressure, as it could worsen **myocardial contractility** and perfusion. *Fentanyl* - Fentanyl is an **opioid analgesic** that primarily causes respiratory depression and can lead to bradycardia, but its direct myocardial depressant effects are generally minimal compared to other agents and it can maintain hemodynamics. - While it can cause bradycardia, it does not typically cause the profound hypotensive and myocardial depression seen with dexmedetomidine, especially when used appropriately. *Etomidate* - Etomidate is a **hemodynamically stable induction agent** that has minimal effects on heart rate, blood pressure, and myocardial contractility, making it a good choice for patients with cardiovascular compromise. - Its main side effect is **adrenocortical suppression**, but it does not cause significant cardiac depression. *Ketamine* - Ketamine generally causes **sympathetic stimulation**, leading to an increase in heart rate and blood pressure by releasing **catecholamines**, which would be beneficial in a hypotensive patient with low cardiac output. - While it can have direct myocardial depressant effects in very high doses, its overall effect is often **cardiovascular stimulation**, making it a relatively good choice in this scenario.

Question 40: Which of the following is not a cardiovascular monitoring technique

A. Transesophageal echocardiography
B. Capnography (Correct Answer)
C. Pulmonary artery catheterization
D. Central venous pressure monitoring

Explanation: ***Capnography*** - **Capnography** is primarily used to monitor **ventilatory status** by measuring the concentration of carbon dioxide in respiratory gases. - While respiratory and cardiovascular systems are interconnected, capnography directly assesses **pulmonary function** and **CO2 elimination**, not intrinsic cardiovascular hemodynamics. *Transesophageal echocardiography* - **Transesophageal echocardiography (TEE)** provides detailed images of the heart's structure and function, including valve function, chamber size, and myocardial contractility. - It is a direct and highly effective method for **cardiovascular assessment** and monitoring during surgical procedures or in critically ill patients. *Pulmonary artery catheterization* - **Pulmonary artery catheterization (PAC)**, also known as Swan-Ganz catheter, directly measures pressures within the right atrium, right ventricle, and pulmonary artery, as well as cardiac output. - This technique provides comprehensive **hemodynamic data** essential for cardiovascular monitoring in critical care settings. *Central venous pressure monitoring* - **Central venous pressure (CVP) monitoring** measures the pressure in the vena cava or right atrium, reflecting the patient's **fluid status** and right ventricular preload. - It is a key parameter for assessing circulatory volume and guiding fluid management in patients with cardiovascular instability.

Question 41: The most sensitive and practical technique for detection of myocardial ischemia in the perioperative period is -

A. Direct measurement of end diastolic pressure
B. Radio labeled lactate determination
C. Magnetic Resonance Spectroscopy
D. Regional wall motion abnormality detected with the help of 2D transoesophageal echocardiography (Correct Answer)

Explanation: ***Regional wall motion abnormality detected with the help of 2D transesophageal echocardiography*** - **Transesophageal echocardiography (TEE)** provides high-resolution images of the heart, allowing for the sensitive detection of **regional wall motion abnormalities (RWMA)**, an early and practical indicator of myocardial ischemia in the perioperative setting. - The development of new or worsening RWMA is often the **first sign of ischemia**, preceding ECG changes or hemodynamic alterations, making it a highly sensitive and clinically useful tool. *Direct measurement of end-diastolic pressure* - While an elevated **end-diastolic pressure** can indicate ventricular dysfunction, it is an **indirect sign** and not specific enough for early myocardial ischemia detection. - This measurement often requires invasive monitoring, which is less practical for routine detection compared to TEE. *Radio-labeled lactate determination* - **Lactate production** can increase in ischemic tissue, but its detection is a **biochemical marker** that typically lags behind the onset of ischemia. - This technique is generally **research-oriented** and not a practical, bedside method for rapid perioperative ischemia detection. *Magnetic Resonance Spectroscopy* - **Magnetic Resonance Spectroscopy (MRS)** can provide detailed metabolic information about tissue, including changes related to ischemia. - However, it is a **complex, time-consuming, and expensive imaging modality** that is not practical for routine, real-time perioperative monitoring of myocardial ischemia.

Question 42: Among the following anesthetic agents, portal vein flow is maximally reduced by:

A. Isoflurane
B. Halothane (Correct Answer)
C. Ether
D. Enflurane

Explanation: ***Halothane*** - **Halothane** causes the most significant reduction in **portal vein blood flow** due to its potent direct **myocardial depression** and systemic vasodilation, leading to a decrease in **hepatic perfusion pressure**. - Its effects can significantly compromise liver oxygen supply, particularly in patients with pre-existing hepatic dysfunction, making it less favorable for liver surgery compared to newer agents. *Isoflurane* - While **isoflurane** can reduce **portal vein flow**, it tends to maintain overall **hepatic oxygen delivery** better than halothane due to its favorable effect on the **hepatic arterial buffer response**. - It causes less profound **myocardial depression** and may maintain a more stable **hepatic blood flow** compared to halothane. *Ether* - **Ether** is an older anesthetic agent that is rarely used in modern practice due to its flammability and slower induction/recovery times. - Its effects on **portal vein flow** are less pronounced compared to halothane, and it generally maintains **hepatic blood flow** more effectively. *Enflurane* - **Enflurane** also causes **dose-dependent reductions** in **portal vein flow**, but generally less severely than halothane. - It can cause **renal toxicity** due to fluoride metabolites and is generally less favored than isoflurane or sevoflurane for maintaining optimal organ perfusion.

Question 43: Which sensitizes the myocardium to catecholamines?

A. Desflurane
B. Halothane (Correct Answer)
C. Isoflurane
D. Nitrous oxide

Explanation: **Halothane** - Halothane is known to **sensitize the myocardium to the arrhythmogenic effects of circulating catecholamines**, increasing the risk of ventricular arrhythmias, particularly in the presence of exogenous adrenaline. - This sensitization is thought to be due to its influence on **calcium handling** within myocardial cells and its effects on ion channels. *Desflurane* - Desflurane, similar to isoflurane and sevoflurane, has a **minimal effect on myocardial sensitization to catecholamines** compared to halothane. - It is generally considered to have a **more favorable cardiovascular profile** regarding arrhythmias. *Isoflurane* - Isoflurane causes **less myocardial sensitization to catecholamines** than halothane and is associated with a lower incidence of arrhythmias in the presence of exogenous adrenaline. - It is often favored over halothane for its **cardiovascular stability** and reduced arrhythmogenic potential. *Nitrous oxide* - Nitrous oxide (N2O) has a **direct myocardial depressant effect** but does not significantly sensitize the myocardium to catecholamines. - When used as a sole anesthetic, its low potency means it generally requires co-administration with other agents, which would then dictate the arrhythmogenic potential.

Question 44: Which drug is used for anesthesia in a hypotensive patient?

A. Ketamine (Correct Answer)
B. Thiopentone
C. Propofol
D. None of the options

Explanation: ***Ketamine*** - **Ketamine** is preferred in hypotensive patients due to its **sympathomimetic effects**, which typically increase **heart rate** and **blood pressure**, thereby supporting cardiovascular stability. - It maintains **cardiac output** and **systemic vascular resistance**, making it a safer option for induction in hemodynamically unstable individuals. *Thiopentone* - **Thiopentone** is a barbiturate that causes significant **cardiovascular depression**, including **hypotension** and decreased cardiac output, making it unsuitable for hypotensive patients. - It can lead to severe drops in **blood pressure**, especially in patients with compromised cardiovascular function or hypovolemia. *Propofol* - **Propofol** is known for its potent **vasodilatory effects** and direct myocardial depression, frequently leading to profound **hypotension**. - Its use is generally avoided in hypotensive patients due to the risk of exacerbating **hemodynamic instability**. *None of the options* - This option is incorrect as **Ketamine** is a well-established anesthetic agent used specifically for its beneficial cardiovascular profile in hypotensive patients.

Question 45: Which of the following is most cardio depressant

A. Sevoflurane
B. Halothane (Correct Answer)
C. Isoflurane
D. Desflurane

Explanation: ***Halothane*** - **Halothane** is known for causing significant **myocardial depression** by directly reducing myocardial contractility and stroke volume. - It also **sensitizes the myocardium to catecholamines**, increasing the risk of arrhythmias. *Sevoflurane* - **Sevoflurane** causes less **myocardial depression** and is often preferred in patients with compromised cardiac function. - Its effects on heart rate and blood pressure are generally moderate compared to halothane. *Isoflurane* - **Isoflurane** can cause **systemic vasodilation** and a dose-dependent decrease in blood pressure but is generally less cardio-depressant than halothane. - It maintains **cardiac output** better than halothane, sometimes increasing heart rate to compensate for vasodilation. *Desflurane* - **Desflurane** typically causes a **lesser degree of myocardial depression** and tends to preserve cardiac output. - It can, however, lead to transient increases in heart rate and blood pressure upon rapid increases in concentration due to **sympathetic stimulation**.

Question 46: Drug that does not cause cardiac depression:

A. Thiopentone
B. Ketamine
C. Propofol
D. Etomidate (Correct Answer)

Explanation: ***Etomidate*** - Etomidate is known for its **cardiovascular stability**, making it a preferred induction agent in patients with **compromised cardiac function**. - It maintains **myocardial contractility** and does not typically cause a significant drop in blood pressure. *Thiopentone* - Thiopentone causes **dose-dependent myocardial depression** and peripheral vasodilation. - This can lead to a significant **decrease in blood pressure** and cardiac output, especially in hypovolemic patients. *Propofol* - Propofol is a potent **vasodilator** and can cause significant **myocardial depression**, leading to hypotension. - Its cardiovascular effects are often more pronounced than those of other induction agents, necessitating careful titration. *Ketamine* - Ketamine causes indirect cardiovascular stimulation (due to **sympathetic nervous system activation**), but direct myocardial depression. - While it often increases heart rate and blood pressure, this is a compensatory mechanism and its direct effect on the myocardium is depressant.

Question 47: A 65-year-old male with a history of chronic heart failure is undergoing hip replacement. Which intraoperative management strategy is most appropriate for maintaining hemodynamic stability?

A. Avoiding excessive fluid administration (Correct Answer)
B. Maintaining elevated heart rate
C. Using vasodilators cautiously
D. Increasing preload moderately

Explanation: **Avoiding excessive fluid administration** - Patients with **chronic heart failure** are prone to **fluid overload**, which can lead to pulmonary edema and worsened cardiac function due to increased **intravascular volume** and **cardiac preload**. - **Careful fluid management** minimizes the risk of perioperative cardiac decompensation and ensures hemodynamic stability. *Maintaining elevated heart rate* - An **elevated heart rate** in a patient with heart failure can drastically increase myocardial oxygen demand and reduce diastolic filling time, potentially leading to **myocardial ischemia** and **cardiac decompensation**. - Maintaining a **normal or slightly reduced heart rate** is generally preferred to optimize cardiac output and minimize cardiac stress. *Using vasodilators cautiously* - While vasodilators can reduce **afterload** and improve cardiac output, their use must be extremely cautious in hip replacement surgery due to potential for significant **hypotension** and **reduced organ perfusion**. - The primary concern during surgery is often blood loss and fluid shifts, which already predispose to hypotension, making aggressive vasodilation risky. *Increasing preload moderately* - Moderately increasing preload can be beneficial in some patients, but in those with **chronic heart failure**, even moderate increases can quickly lead to **pulmonary congestion** and cardiac decompensation. - The failing heart has a limited ability to handle increased volume, meaning that optimizing preload typically involves avoiding both hypovolemia and hypervolemia through **precise fluid titration**.

Question 48: A 70-year-old male with a history of ischemic heart disease is undergoing emergency femur fracture repair. Which intraoperative complication is he at the highest risk for?

A. Cerebral embolism (Correct Answer)
B. Pulmonary edema
C. Renal failure
D. Myocardial infarction

Explanation: ***Cerebral embolism*** - Patients undergoing **orthopedic surgery**, especially for **femur fractures**, are at risk for **fat embolism syndrome**, which can lead to cerebral emboli. This risk is compounded by the pre-existing **ischemic heart disease** (IHD) which suggests underlying atherosclerosis, increasing vulnerability to embolic events overall. - The surgical manipulation of the bone marrow releases **fat globules** into the bloodstream which can travel to the brain, causing **neurological deficits** such as confusion, focal neurological signs, and even coma. *Pulmonary edema* - While possible in patients with IHD, **pulmonary edema** is typically associated with fluid overload or severe cardiac dysfunction. - Although general anesthesia and surgery can contribute to fluid shifts, the most immediate and specific complication for bone fracture repair is related to bone marrow release. *Renal failure* - **Acute renal failure** can occur post-operatively due to hypoperfusion, nephrotoxic drugs, or sepsis. - However, it's not the highest or most direct risk specifically associated with femur fracture repair in a patient with IHD compared to embolic events. *Myocardial infarction* - Patients with IHD are at an increased risk of **perioperative myocardial infarction (MI)** due to surgical stress and changes in hemodynamic parameters. - While a significant concern, the direct immediate risk from the bone manipulation during a femur fracture repair specifically points towards embolic phenomena, making cerebral embolism a slightly higher risk in this context.

Question 49: A 50-year-old female with a history of coronary artery disease is undergoing an elective laparoscopic cholecystectomy. Which anesthetic agent is preferred to minimize myocardial oxygen consumption?

A. Desflurane
B. Nitrous oxide
C. Sevoflurane (Correct Answer)
D. Isoflurane

Explanation: ***Sevoflurane*** - **Sevoflurane** is preferred due to its ability to maintain **hemodynamic stability** and minimize **myocardial oxygen consumption**, which is crucial in patients with **coronary artery disease (CAD)**. - It has a relatively **low pungency**, making it suitable for inhalation induction and reducing airway irritation that could trigger adverse cardiac events. *Desflurane* - **Desflurane** is associated with a **more rapid increase in heart rate and blood pressure** upon induction and changes in anesthetic depth, which increases **myocardial oxygen demand** and can be detrimental in CAD patients. - Its **pungent odor** can cause airway irritation, coughing, and laryngospasm, further stressing the cardiovascular system. *Nitrous oxide* - **Nitrous oxide (N2O)** should be used with caution or avoided in CAD patients because it can cause **vasoconstriction** and potentially increase **pulmonary vascular resistance**, thus increasing cardiac workload. - It also has a **low potency**, requiring co-administration with other agents, and can expand air-filled spaces, posing risks during laparoscopic surgery. *Isoflurane* - While **isoflurane** has cardioprotective properties, it can cause **coronary steal phenomenon** at deeper anesthetic depths, where blood flow is diverted from ischemic areas to non-ischemic areas, potentially worsening ischemia. - Its **stronger pungent odor** compared to sevoflurane can lead to airway irritation and coughing, which is undesirable in patients with compromised cardiac function.

Question 50: A 50-year-old female with a history of mitral stenosis is scheduled for an elective cholecystectomy. Which intraoperative monitoring is most appropriate for this patient?

A. Central venous pressure monitoring
B. Continuous ECG monitoring
C. Pulmonary artery catheter
D. Invasive arterial blood pressure monitoring (Correct Answer)

Explanation: ***Invasive arterial blood pressure monitoring*** - This provides **beat-to-beat blood pressure readings**, which are crucial for immediate detection and management of hemodynamic changes during surgery in a patient with significant cardiac disease like **mitral stenosis**. - Mitral stenosis patients are prone to acute hemodynamic instability, and **invasive arterial monitoring** allows continuous assessment of systemic vascular resistance and cardiac output indirectly, guiding anesthetic management. *Pulmonary artery catheter* - While it provides detailed information on **cardiac output**, **pulmonary artery pressures**, and **pulmonary capillary wedge pressure**, its use is typically reserved for more complex cases or patients with severe ventricular dysfunction or pulmonary hypertension, and is associated with some risks. - For an elective cholecystectomy in a patient with stable mitral stenosis, the risks likely outweigh the benefits compared to less invasive but still highly informative monitoring. *Central venous pressure monitoring* - **CVP monitoring** primarily reflects **right atrial pressure** and intravascular volume status, which is less specific for assessing the hemodynamic impact of mitral stenosis on left heart function. - While useful for guiding fluid management, it does not provide direct, continuous feedback on systemic blood pressure changes, which are critically important in a patient with mitral stenosis undergoing surgery. *Continuous ECG monitoring* - **Continuous ECG monitoring** is standard for all surgical patients to detect arrhythmias and ischemia, but it does not provide information on the **hemodynamic consequences** of these events or the overall circulatory status. - While essential, it is insufficient on its own for a patient with mitral stenosis, who requires more direct assessment of **blood pressure** and cardiac function to manage potential hemodynamic instability.

Question 51: A 65-year-old male with a history of hypertension, coronary artery disease, and chronic kidney disease is scheduled for aortic aneurysm repair. Evaluate the potential complications and select the best intraoperative management strategy.

A. Aggressive fluid administration to maintain blood pressure
B. Controlled hypotension with vasodilators to reduce blood loss (Correct Answer)
C. Use of high-dose opioids to minimize stress response
D. Intraoperative diuresis to prevent fluid overload

Explanation: **Controlled hypotension with vasodilators to reduce blood loss** - This strategy helps **minimize blood loss** during aortic aneurysm repair, which is crucial in patients with comorbidities like **coronary artery disease** and **chronic kidney disease**, reducing the need for transfusions and their associated risks. - **Controlled hypotension** reduces **cardiac afterload** and **myocardial oxygen demand**, which is beneficial for a patient with **hypertension** and **coronary artery disease**. *Aggressive fluid administration to maintain blood pressure* - **Aggressive fluid administration** can lead to **fluid overload**, particularly in a patient with **chronic kidney disease** and **cardiac comorbidities**, exacerbating heart failure or pulmonary edema. - While maintaining blood pressure is important, **aggressive fluid administration** alone without careful monitoring can cause more complications than benefits in this high-risk patient. *Use of high-dose opioids to minimize stress response* - High-dose opioids can cause significant **respiratory depression** and **hemodynamic instability**, which are particularly risky in a patient with **cardiovascular disease** and **chronic kidney disease**. - While opioids are part of anesthesia, **high-dose strategies** should be balanced against their potential adverse effects on ventilation and circulation. *Intraoperative diuresis to prevent fluid overload* - **Intraoperative diuresis** can worsen **hypovolemia** and **renal perfusion**, which is detrimental in a patient with **chronic kidney disease** facing a major vascular procedure, potentially leading to acute kidney injury. - Diuresis should only be considered after adequate fluid resuscitation and only if true fluid overload is confirmed, not as a primary preventive measure against it during a surgery with significant blood loss potential.

Question 52: A 70-year-old male with a history of diabetes is undergoing surgery. During the operation, he develops signs of myocardial ischemia. Which intraoperative management step is the most appropriate?

A. Increase the rate of intravenous fluids
B. Administer nitroglycerin (Correct Answer)
C. Administer beta-blockers
D. Increase the depth of anesthesia

Explanation: ***Administer nitroglycerin*** - **Nitroglycerin** causes **vasodilation**, which can improve blood flow to the heart and reduce myocardial oxygen demand, effectively treating **myocardial ischemia**. - It is particularly useful in an acute setting to rapidly alleviate symptoms and prevent further damage. *Increase the rate of intravenous fluids* - Increasing intravenous fluids could lead to **fluid overload**, potentially worsening cardiac function in a patient with myocardial ischemia, especially if cardiac output is already compromised. - This intervention would be more appropriate for **hypovolemia rather than ischemia**. *Administer beta-blockers* - While beta-blockers reduce heart rate and contractility, which are beneficial for myocardial oxygen demand, they can also cause **hypotension** or **bradycardia**, which could exacerbate ischemia or compromise tissue perfusion if not carefully titrated. - Their full effect is not immediate, making them less suitable for **acute intraoperative management** compared to nitroglycerin. *Increase the depth of anesthesia* - Increasing anesthetic depth generally leads to **hypotension** and **decreased cardiac output**, which could further compromise coronary perfusion and worsen myocardial ischemia. - The goal during ischemia is to improve cardiac function and oxygen supply, not to suppress it further.

Question 53: Which one of the following agents sensitizes the myocardium to catecholamines?

A. Isoflurane
B. Ether
C. Halothane (Correct Answer)
D. Propofol

Explanation: ***Halothane*** - **Halothane** sensitizes the myocardium to the arrhythmogenic effects of **catecholamines**, leading to an increased risk of ventricular arrhythmias, especially in the presence of exogenous adrenaline. - This sensitization occurs due to its effect on myocardial **calcium ion** regulation and increased automaticity in cardiac pacemaker cells. *Isoflurane* - **Isoflurane** causes minimal sensitization of the myocardium to catecholamines compared to halothane. - It maintains **cardiac output** with a dose-dependent decrease in systemic vascular resistance. *Ether* - **Diethylether** historically caused sympathetic stimulation, which could mask some depressant effects but did not primarily sensitize the myocardium to arrhythmias from exogenous catecholamines. - Its use has largely been replaced due to its flammability and slower induction/recovery. *Propofol* - **Propofol** generally causes myocardial depression and vasodilation, but it does **not sensitize** the myocardium to catecholamines in a clinically significant way that increases arrhythmogenic risk. - It often leads to a decrease in **blood pressure** and heart rate.

Question 54: What is the most effective method to monitor intraoperative myocardial ischemia?

A. ECG
B. CVP monitoring
C. Invasive intracarotid arterial pressure
D. Transesophageal echocardiography (Correct Answer)

Explanation: ***Transesophageal echocardiography*** - **Transesophageal echocardiography (TEE)** provides direct visualization of myocardial wall motion abnormalities, which are early and sensitive indicators of ischemia. - TEE can detect **regional wall motion abnormalities** before ECG changes or hemodynamic alterations occur. *ECG* - While an **ECG** can detect ST-segment changes indicative of ischemia, these changes often appear later than **regional wall motion abnormalities** and may be masked by other intraoperative factors. - Its sensitivity for detecting intraoperative ischemia is lower compared to TEE, especially in patients with pre-existing conduction abnormalities. *CVP monitoring* - **Central venous pressure (CVP)** monitoring primarily assesses **right ventricular preload** and systemic fluid status. - It does not directly provide information about myocardial oxygen supply and demand balance or the presence of **ischemia**. *Invasive intracarotid arterial pressure* - **Invasive arterial pressure monitoring** provides continuous and accurate blood pressure readings, which are crucial for maintaining tissue perfusion. - However, it measures systemic arterial pressure and does not directly monitor for **myocardial ischemia**.

Question 55: All of the following cause myocardial depression except:

A. Halothane
B. Thiopentone
C. Etomidate (Correct Answer)
D. Ketamine

Explanation: ***Etomidate*** - **Etomidate** is known for its **hemodynamic stability** and minimal effect on myocardial contractility, making it a suitable induction agent for patients with cardiovascular compromise. - While it can cause some decrease in systemic vascular resistance, it maintains **cardiac output** much better than other agents listed. *Halothane* - **Halothane** is a potent volatile anesthetic that directly depresses **myocardial contractility** and reduces cardiac output. - It sensitizes the myocardium to **catecholamines**, increasing the risk of arrhythmias. *Thiopentone* - **Thiopentone** (thiopental) is a barbiturate that causes significant **dose-dependent myocardial depression** and systemic vasodilation. - This can lead to a substantial decrease in **blood pressure** and cardiac output, especially with rapid administration. *Ketamine* - Although ketamine often causes an increase in heart rate and blood pressure due to **sympathetic stimulation**, it can also have a direct **myocardial depressant effect** when the sympathetic nervous system is exhausted or blocked. - Its indirect stimulant effects *can mask* a direct negative inotropic effect on the myocardium.

Question 56: Which of the following inhalational agents can cause a coronary steal phenomenon?

A. Isoflurane (Correct Answer)
B. Sevoflurane
C. Desflurane
D. Halothane

Explanation: ***Isoflurane*** - **Isoflurane** is a potent coronary vasodilator, and at higher concentrations, it can preferentially dilate healthy coronary arteries. - This diversion of blood flow away from stenosed or diseased areas of the myocardium can lead to **myocardial ischemia**, known as the **coronary steal phenomenon**. *Sevoflurane* - **Sevoflurane** has minimal effects on coronary autoregulation and is considered to have a lower risk of inducing coronary steal due to its balanced vasodilatory properties. - It is often preferred in patients with **coronary artery disease** due to its favorable cardiac profile. *Desflurane* - **Desflurane** causes some coronary vasodilation but is less prone to causing coronary steal compared to isoflurane. - Its primary cardiovascular effects include a dose-dependent decrease in systemic vascular resistance and an increase in **heart rate**. *Halothane* - **Halothane** is known for its myocardial depressant effects and does not cause significant coronary vasodilation or the coronary steal phenomenon. - It can cause **bradycardia** and **arrhythmias**, particularly in the presence of catecholamines.

Practice by Chapter

Cardiovascular Physiology

Practice Questions

Anesthesia for Coronary Artery Disease

Practice Questions

Valvular Heart Disease Management

Practice Questions

Congenital Heart Disease in Adults

Practice Questions

Cardiopulmonary Bypass Principles

Practice Questions

Myocardial Protection Strategies

Practice Questions

Inotropes and Vasopressors

Practice Questions

Vasodilators in Cardiac Anesthesia

Practice Questions

Transesophageal Echocardiography

Practice Questions

Off-Pump Cardiac Surgery

Practice Questions

Management of Cardiac Pacemakers and ICDs

Practice Questions

Fast-Track Cardiac Anesthesia

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free